EBA
MCID: EPD006
MIFTS: 49

Epidermolysis Bullosa Acquisita (EBA)

Categories: Rare diseases, Skin diseases

Aliases & Classifications for Epidermolysis Bullosa Acquisita

MalaCards integrated aliases for Epidermolysis Bullosa Acquisita:

Name: Epidermolysis Bullosa Acquisita 12 74 52 58 54 43 15 17 71
Acquired Epidermolysis Bullosa 12 52 58 32
Eb Acquisita 52
Eba 52

Characteristics:

Orphanet epidemiological data:

58
epidermolysis bullosa acquisita
Inheritance: Not applicable; Age of onset: Adult;

Classifications:

Orphanet: 58  
Rare skin diseases


External Ids:

Disease Ontology 12 DOID:4313
MeSH 43 D016107
NCIt 49 C84690
SNOMED-CT 67 2772003
ICD10 32 L12.3 L12.30
ICD10 via Orphanet 33 L12.3
UMLS via Orphanet 72 C0079293
Orphanet 58 ORPHA46487
UMLS 71 C0079293

Summaries for Epidermolysis Bullosa Acquisita

NIH Rare Diseases : 52 Epidermolysis bullosa acquisita (EBA) is a rare autoimmune disorder that causes the skin to blister in response to minor injury. Common areas of blistering include the hands, feet, knees, elbows, and buttocks. It can also affect the mouth, nose, and eyes. Some affected people have other health problems such as Crohn's disease , systemic lupus erythematosus , amyloidosis , or multiple myeloma . EBA is not inherited and usually occurs in adulthood. Treatment aims to protect the skin, stop the formation of blisters, and promote healing. Immunosuppressive drugs may be used to reduce the body's autoimmune response.

MalaCards based summary : Epidermolysis Bullosa Acquisita, also known as acquired epidermolysis bullosa, is related to ocular cicatricial pemphigoid and bullous pemphigoid. An important gene associated with Epidermolysis Bullosa Acquisita is COL7A1 (Collagen Type VII Alpha 1 Chain), and among its related pathways/superpathways are PI3K-Akt signaling pathway and Phospholipase-C Pathway. The drugs Methoxsalen and Dermatologic Agents have been mentioned in the context of this disorder. Affiliated tissues include skin, eye and neutrophil, and related phenotypes are abnormal blistering of the skin and abnormal hair morphology

Disease Ontology : 12 An acquired epidermolysis bullosa that is characterized by formation of recurrent blisters secondary to minor trauma in the skin and mucosa, and has material basis in the development of autoantibodies to type VII collagen.

Wikipedia : 74 Epidermolysis bullosa acquisita is a chronic subepidermal blistering disease associated with... more...

Related Diseases for Epidermolysis Bullosa Acquisita

Diseases related to Epidermolysis Bullosa Acquisita via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 161, show less)
# Related Disease Score Top Affiliating Genes
1 ocular cicatricial pemphigoid 30.9 SERPINH1 ITGB4 HLA-DRB1
2 bullous pemphigoid 30.7 LAMC2 LAMA3 LAD1 ITGB4 HLA-DRB1 DST
3 epidermolysis bullosa dystrophica 30.6 DST COL7A1 COL17A1
4 epidermolysis bullosa 30.2 MATN1 LAMC2 LAMA3 ITGB4 DST COL7A1
5 pemphigus 30.1 HLA-DRB1 DST COL17A1
6 bullous skin disease 30.1 LAMA3 DST COL17A1
7 pemphigus foliaceus 30.0 HLA-DRB1 DST
8 pemphigus vulgaris, familial 29.9 HLA-DRB1 DST COL17A1
9 autoimmune disease 29.8 SYK IL2RA IL21 HLA-DRB1 FCGRT COL17A1
10 pemphigus gestationis 29.7 DST COL17A1
11 linear iga disease 29.6 LAD1 ITGB4 DST COL17A1
12 pemphigoid gestationis 29.3 HLA-DRB1 DST COL17A1
13 paraneoplastic pemphigus 29.3 HLA-DRB1 DST COL17A1
14 skin disease 29.2 LAMC2 LAMA3 LAD1 ITGB4 DST COL7A1
15 cicatricial pemphigoid 28.5 SERPINH1 LAMC2 LAMA3 LAD1 ITGB4 HLA-DRB1
16 junctional epidermolysis bullosa 28.4 LAMC2 LAMA3 ITGB4 DST COL7A1 COL17A1
17 alpha/beta t-cell lymphopenia with gamma/delta t-cell expansion, severe cytomegalovirus infection, and autoimmunity 10.8
18 crohn's disease 10.8
19 systemic lupus erythematosus 10.7
20 lupus erythematosus 10.7
21 anti-p200 pemphigoid 10.7
22 yemenite deaf-blind hypopigmentation syndrome 10.6
23 inflammatory bowel disease 10.6
24 recessive dystrophic epidermolysis bullosa 10.6
25 amyloidosis 10.6
26 dysphagia 10.6
27 pustulosis of palm and sole 10.6
28 conjunctivitis 10.6
29 psoriasis 10.6
30 myeloma, multiple 10.5
31 ulcerative colitis 10.5
32 obsolete: bullous systemic lupus erythematosus 10.5
33 inherited epidermolysis bullosa 10.5
34 porphyria cutanea tarda 10.5
35 dermatitis herpetiformis, familial 10.5
36 erythema multiforme 10.5
37 crohn's colitis 10.5
38 porphyria 10.5
39 dermatitis herpetiformis 10.5
40 hypereosinophilic syndrome 10.5
41 factor viii deficiency 10.4
42 neutrophil migration 10.4
43 hemophilia a 10.4
44 graft-versus-host disease 10.4
45 membranous nephropathy 10.4
46 exanthem 10.4
47 lymphoma 10.4
48 colitis 10.4
49 hypothyroidism 10.4
50 hepatitis c 10.4
51 relapsing polychondritis 10.4
52 dermatitis 10.4
53 cryoglobulinemia 10.4
54 pulmonary tuberculosis 10.4
55 vasculitis 10.4
56 alopecia 10.4
57 acquired hemophilia 10.4
58 ankyloglossia with or without tooth anomalies 10.2
59 cryoglobulinemia, familial mixed 10.2
60 ovarian cancer 10.2
61 sarcoidosis 1 10.2
62 chromosome 2q35 duplication syndrome 10.2
63 vitiligo-associated multiple autoimmune disease susceptibility 6 10.2
64 celiac disease 1 10.2
65 epidermolysis bullosa dystrophica, autosomal recessive 10.2
66 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 10.2
67 pancreatic cancer 10.2
68 wilson disease 10.2
69 immunodysregulation, polyendocrinopathy, and enteropathy, x-linked 10.2
70 dermatitis, atopic 10.2
71 epidermolysis bullosa pruriginosa 10.2
72 vitiligo-associated multiple autoimmune disease susceptibility 1 10.2
73 hepatitis c virus 10.2
74 diabetes mellitus, ketosis-prone 10.2
75 inflammatory bowel disease 25, autosomal recessive 10.2
76 gastrointestinal ulceration, recurrent, with dysfunctional platelets 10.2
77 cutaneous lupus erythematosus 10.2
78 mantle cell lymphoma 10.2
79 inflammatory bowel disease 25 10.2
80 osteonecrosis 10.2
81 nephrotic syndrome 10.2
82 esophagitis 10.2
83 graves' disease 10.2
84 crescentic glomerulonephritis 10.2
85 uveitis 10.2
86 thrombocytopenia 10.2
87 cystitis 10.2
88 squamous cell carcinoma 10.2
89 dental caries 10.2
90 hepatitis 10.2
91 glomerulonephritis 10.2
92 acute kidney failure 10.2
93 gingival overgrowth 10.2
94 gingivitis 10.2
95 neurilemmoma 10.2
96 laryngitis 10.2
97 hyperglycemia 10.2
98 eyelid disease 10.2
99 pneumonia 10.2
100 kidney disease 10.2
101 hemolytic anemia 10.2
102 esophageal disease 10.2
103 plasma cell neoplasm 10.2
104 corneal ulcer 10.2
105 herpes zoster 10.2
106 collagen disease 10.2
107 herpes simplex 10.2
108 viral exanthem 10.2
109 alopecia areata 10.2
110 hemophilia 10.2
111 epidermolysis bullosa with pyloric atresia 10.2
112 acquired hemophilia a 10.2
113 autoimmune enteropathy 10.2
114 cytokine deficiency 10.2
115 stevens-johnson syndrome/toxic epidermal necrolysis 10.2
116 cytomegalovirus infection 10.2
117 subacute cutaneous lupus erythematosus 10.2
118 systemic autoimmune disease 10.2
119 iga pemphigus 10.2
120 autoimmune bullous skin disease 10.2
121 severe immune-mediated enteropathy 10.2
122 polyendocrinopathy 10.2
123 thyroid carcinoma 10.2
124 hair whorl 10.2
125 rheumatoid factor-negative juvenile idiopathic arthritis 10.2 IL2RA HLA-DRB1
126 maternal uniparental disomy of chromosome 1 10.1 LAMC2 LAMA3
127 maternal uniparental disomy 10.1 LAMC2 LAMA3
128 uniparental disomy of chromosome 1 10.1 LAMC2 LAMA3
129 hydrops, lactic acidosis, and sideroblastic anemia 10.1
130 autism spectrum disorder 10.1
131 cerebral artery occlusion 10.1
132 avoidant personality disorder 10.1
133 personality disorder 10.1
134 brain edema 10.1
135 submandibular gland cancer 10.1
136 dilated cardiomyopathy 10.1
137 hepatitis d 10.1
138 tracheal stenosis 10.1
139 liver disease 10.1
140 lymph node tuberculosis 10.1
141 intestinal disease 10.1
142 scabies 10.1
143 red cell aplasia 10.1 IL2RA HLA-DRB1
144 oligoarticular juvenile idiopathic arthritis 10.0 IL2RA HLA-DRB1
145 idiopathic neutropenia 10.0 IL2RA HLA-DRB1
146 chronic mucocutaneous candidiasis 10.0 SYK IL2RA HSP90AA1
147 pure red-cell aplasia 9.9 IL2RA HLA-DRB1
148 nail disorder, nonsyndromic congenital, 4 9.8 COL7A1 COL17A1
149 thrombocytopenia due to platelet alloimmunization 9.8 SYK FCGRT
150 neurotic excoriation 9.5 DST COL7A1 COL17A1
151 epidermolysis bullosa simplex with muscular dystrophy 9.5 LAMA3 DST COL17A1
152 lichen planus pemphigoides 9.5 ITGB4 DST COL17A1
153 autoimmune disease of skin and connective tissue 9.5 LAMA3 DST COL17A1
154 epidermolysis bullosa, junctional, herlitz type 9.4 LAMC2 LAMA3 COL7A1 COL17A1
155 cellulitis 9.4 LAMA3 DST COL17A1
156 pyloric atresia 9.4 LAMC2 LAD1 ITGB4 COL17A1
157 kindler syndrome 9.3 ITGB4 DST COL7A1 COL17A1
158 epidermolysis bullosa simplex 9.3 ITGB4 DST COL7A1 COL17A1
159 epidermolysis bullosa junctionalis with pyloric atresia 8.9 LAMC2 LAMA3 ITGB4 DST COL17A1
160 vesiculobullous skin disease 8.7 LAMC2 LAMA3 ITGB4 DST COL7A1 COL17A1
161 epidermolysis bullosa, junctional, non-herlitz type 8.6 LAMC2 LAMA3 LAD1 ITGB4 DST COL7A1

Graphical network of the top 20 diseases related to Epidermolysis Bullosa Acquisita:



Diseases related to Epidermolysis Bullosa Acquisita

Symptoms & Phenotypes for Epidermolysis Bullosa Acquisita

Human phenotypes related to Epidermolysis Bullosa Acquisita:

58 31 (showing 11, show less)
# Description HPO Frequency Orphanet Frequency HPO Source Accession
1 abnormal blistering of the skin 58 31 hallmark (90%) Very frequent (99-80%) HP:0008066
2 abnormal hair morphology 31 hallmark (90%) HP:0001595
3 milia 58 31 frequent (33%) Frequent (79-30%) HP:0001056
4 diabetes mellitus 58 31 occasional (7.5%) Occasional (29-5%) HP:0000819
5 abdominal pain 58 31 occasional (7.5%) Occasional (29-5%) HP:0002027
6 nail dystrophy 58 31 occasional (7.5%) Occasional (29-5%) HP:0008404
7 pruritus 58 31 occasional (7.5%) Occasional (29-5%) HP:0000989
8 atypical scarring of skin 58 31 occasional (7.5%) Occasional (29-5%) HP:0000987
9 inflammation of the large intestine 58 31 occasional (7.5%) Occasional (29-5%) HP:0002037
10 hyperpigmentation of the skin 58 31 occasional (7.5%) Occasional (29-5%) HP:0000953
11 abnormality of the hair 58 Very frequent (99-80%)

GenomeRNAi Phenotypes related to Epidermolysis Bullosa Acquisita according to GeneCards Suite gene sharing:

26 (showing 21, show less)
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Decreased shRNA abundance (Z-score < -2) GR00366-A-104 9.74 COL7A1 IL21 IL2RA LAMA3
2 Decreased shRNA abundance (Z-score < -2) GR00366-A-130 9.74 IL2RA
3 Decreased shRNA abundance (Z-score < -2) GR00366-A-134 9.74 IL2RA
4 Decreased shRNA abundance (Z-score < -2) GR00366-A-139 9.74 LAMA3
5 Decreased shRNA abundance (Z-score < -2) GR00366-A-179 9.74 IL2RA
6 Decreased shRNA abundance (Z-score < -2) GR00366-A-18 9.74 LAMA3
7 Decreased shRNA abundance (Z-score < -2) GR00366-A-181 9.74 COL7A1 IL2RA
8 Decreased shRNA abundance (Z-score < -2) GR00366-A-184 9.74 IL21
9 Decreased shRNA abundance (Z-score < -2) GR00366-A-204 9.74 COL7A1 LAMA3
10 Decreased shRNA abundance (Z-score < -2) GR00366-A-213 9.74 IL2RA
11 Decreased shRNA abundance (Z-score < -2) GR00366-A-27 9.74 IL21
12 Decreased shRNA abundance (Z-score < -2) GR00366-A-28 9.74 IL21
13 Decreased shRNA abundance (Z-score < -2) GR00366-A-34 9.74 IL2RA
14 Decreased shRNA abundance (Z-score < -2) GR00366-A-48 9.74 COL7A1
15 Decreased shRNA abundance (Z-score < -2) GR00366-A-53 9.74 COL7A1
16 Decreased shRNA abundance (Z-score < -2) GR00366-A-72 9.74 IL21
17 Decreased shRNA abundance (Z-score < -2) GR00366-A-86 9.74 LAMA3
18 Decreased shRNA abundance (Z-score < -2) GR00366-A-89 9.74 IL21
19 Decreased shRNA abundance (Z-score < -2) GR00366-A-91 9.74 COL7A1
20 Decreased shRNA abundance (Z-score < -2) GR00366-A-95 9.74 COL7A1
21 Decreased shRNA abundance (Z-score < -2) GR00366-A-98 9.74 LAMA3

MGI Mouse Phenotypes related to Epidermolysis Bullosa Acquisita:

45 (showing 3, show less)
# Description MGI Source Accession Score Top Affiliating Genes
1 craniofacial MP:0005382 9.63 COL7A1 HSP90AA1 ITGB4 LAMA3 LAMC2 SERPINH1
2 immune system MP:0005387 9.61 FCGRT HSP90AA1 IL21 IL2RA ITGB4 LAMA3
3 respiratory system MP:0005388 9.17 IL2RA ITGB4 LAMA3 LAMC2 RORA SERPINH1

Drugs & Therapeutics for Epidermolysis Bullosa Acquisita

Drugs for Epidermolysis Bullosa Acquisita (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 10, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Methoxsalen Approved Phase 2 298-81-7 4114
2 Dermatologic Agents Phase 2
3 Photosensitizing Agents Phase 2
4
Tacrolimus Approved, Investigational Early Phase 1 104987-11-3 445643 439492 6473866
5
Lorazepam Approved Early Phase 1 846-49-1 3958
6
Fludarabine Approved Early Phase 1 21679-14-1, 75607-67-9 30751
7
Busulfan Approved, Investigational Early Phase 1 55-98-1 2478
8
alemtuzumab Approved, Investigational Early Phase 1 216503-57-0
9 Immunologic Factors
10 Autoantibodies

Interventional clinical trials:

(showing 6, show less)
# Name Status NCT ID Phase Drugs
1 Phase II Pilot Study of Extracorporeal Phototherapy for Epidermolysis Bullosa Acquisita Completed NCT00004359 Phase 2 methoxsalen
2 Genetic Susceptibility and Influence of the Microbiomae in Bullous Pemphigoid Unknown status NCT02874079
3 A Pilot Study of Reduced Intensity Conditioning (RIC) and Allogeneic Stem Cell Transplantation (ALLOSCT) In Children With Recessive Dystrophic Epidermolysis Bullosa (RDEB) Unknown status NCT00881556 Early Phase 1 Reduced Intensity Transplant conditioning
4 A Controlled Cross Sectional Study: Prevalence of Cutaneous Autoimmune Phenomena in HIV Infected Patients Completed NCT03129308
5 Establishment of the National Epidermolysis Bullosa Registry Completed NCT00004761
6 Assessment of the Enrichment of Rare Coding Genetic Variants in Patients Affected by Neutrophil-Mediated Inflammatory Dermatoses Recruiting NCT01952275

Search NIH Clinical Center for Epidermolysis Bullosa Acquisita

Cochrane evidence based reviews: epidermolysis bullosa acquisita

Genetic Tests for Epidermolysis Bullosa Acquisita

Anatomical Context for Epidermolysis Bullosa Acquisita

MalaCards organs/tissues related to Epidermolysis Bullosa Acquisita:

40
Skin, Eye, Neutrophil, T Cells, Liver, Kidney, Testes

Publications for Epidermolysis Bullosa Acquisita

Articles related to Epidermolysis Bullosa Acquisita:

(showing 856, show less)
# Title Authors PMID Year
1
C4d immunohistochemical stain is a sensitive method to confirm immunoreactant deposition in formalin-fixed paraffin-embedded tissue in bullous pemphigoid. 54 61
19515044 2009
2
The cartilage matrix protein subdomain of type VII collagen is pathogenic for epidermolysis bullosa acquisita. 54 61
17525268 2007
3
Autoimmune subepidermal blistering diseases in Uganda: correlation of autoantibody class with age of patients. 54 61
16961507 2006
4
A case of mixed bullous disease of epidermolysis bullosa acquisita and linear IgA bullous dermatosis. 54 61
16088162 2005
5
A comparative study of antibody titers of blister fluid and serum in patients with subepidermal immunobullous diseases. 54 61
15117364 2004
6
Crescentic glomerulonephritis and subepidermal blisters with autoantibodies to alpha5 and alpha6 chains of type IV collagen. 54 61
12746470 2003
7
IgA-mediated epidermolysis bullosa acquisita: two cases and review of the literature. 54 61
12451379 2002
8
Inflammatory variant of epidermolysis bullosa acquisita with IgG autoantibodies against type VII collagen and laminin alpha3. 54 61
10677099 2000
9
Epidermal adhesion molecules and basement membrane components as target structures of autoimmunity. 54 61
9672190 1998
10
Acquired subepidermal bullous diseases associated with psoriasis: a clinical, immunopathological and immunogenetic study. 54 61
8977674 1996
11
Autoantibodies to bullous pemphigoid and epidermolysis bullosa acquisita antigens in an infant. 54 61
8949441 1996
12
The 105-kDa basement membrane autoantigen p105 is N-terminally homologous to a tumor-associated antigen. 54 61
8757764 1996
13
Identification of a 168-kDa mucosal antigen in a subset of patients with cicatricial pemphigoid. 54 61
8752852 1996
14
A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone. 54 61
8752680 1996
15
A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone. 54 61
8648178 1996
16
A case of generalized pustular psoriasis followed by bullous disease: an atypical case of bullous pemphigoid or a novel bullous disease? 54 61
8745904 1996
17
Fluorescence overlay antigen mapping of the epidermal basement membrane zone: III. Topographic staining and effective resolution. 54 61
7608519 1995
18
Indirect immunohistochemistry and immunoelectron microscopy distribution of eight epidermal-dermal junction epitopes in the pig and in isolated perfused skin treated with bis (2-chloroethyl) sulfide. 54 61
7544906 1995
19
Identification and partial characterization of a novel 105-kDalton lower lamina lucida autoantigen associated with a novel immune-mediated subepidermal blistering disease. 54 61
8370962 1993
20
Application of an image analyzer to gold labeling in immunoelectron microscopy to achieve better demonstration and quantitative analysis. 54 61
8417107 1993
21
Cryofixed, freeze-dried and paraffin-embedded skin enables successful immunohistochemical staining of skin basement membrane antigens. 54 61
1385370 1992
22
Ultrastructural immunogold studies in two cases of linear IgA dermatosis. Are there two distinct types of this disease? 54 61
1390137 1992
23
The site of blister formation in dermatitis herpetiformis is within the lamina lucida. 54 61
1430358 1992
24
Basement membrane and fibroblast aberration in blisters at the donor, graft, and spontaneously healed sites in patients with burns. 54 61
1739295 1992
25
Direct immunofluorescence microscopy of 1 mol/L sodium chloride-treated patient skin. 54 61
1869682 1991
26
Lichen planus pemphigoides: case report and results of immunofluorescence and immunoelectron microscopic study. 54 61
2180994 1990
27
Expression of extracellular and intracellular bullous pemphigoid antigens at the dermal-epibolic junction in organ culture of human skin. 54 61
2407787 1990
28
Ocular involvement in epidermolysis bullosa acquisita with long-term follow-up. 61
31088794 2020
29
Anti-neonatal Fc receptor (FcRn) antibody treatment ameliorates experimental epidermolysis bullosa acquisita in mice. 61
31975370 2020
30
Japanese guidelines for the management of pemphigoid (including epidermolysis bullosa acquisita). 61
31646663 2019
31
Epidermolysis Bullosa Acquisita: A Case Report of a Rare Clinical Phenotype and a Review of Literature. 61
31938664 2019
32
From bench to bedside: evolving therapeutic targets in autoimmune blistering disease. 61
31314932 2019
33
The Sphingosine-1-Phosphate Receptor Modulator Fingolimod Aggravates Murine Epidermolysis Bullosa Acquisita. 61
31176709 2019
34
Efficacy of intravenous immunoglobulins for laryngopharyngeal lesions and upper airway obstruction in epidermolysis bullosa acquisita. 61
31730256 2019
35
Bullous Diseases in Children: A Review of Clinical Features and Treatment Options. 61
31506891 2019
36
Mucous membrane pemphigoid and oral blistering diseases. 61
31102296 2019
37
Review of autoimmune blistering diseases: the Pemphigoid diseases. 61
31087464 2019
38
Dual inhibition of complement factor 5 and leukotriene B4 synergistically suppresses murine pemphigoid disease. 61
31391346 2019
39
Epidermolysis bullosa acquisita: A comprehensive review. 61
31181325 2019
40
Alopecia in Autoimmune Blistering Diseases: A Systematic Review of Pathogenesis and Clinical Features of Disease. 61
31559249 2019
41
Successful treatment of refractory epidermolysis bullosa acquisita with intravenous immunoglobulin and dapsone. 61
31603972 2019
42
Optimization of reference gene panels for gene expression analysis in preclinical models of inflammatory skin diseases. 61
31177560 2019
43
Type VII collagen IgE autoantibodies in epidermolysis bullosa acquisita: more common than suspected. 61
31025734 2019
44
Detection of anti-type VII collagen IgE antibodies in epidermolysis bullosa acquisita. 61
30311191 2019
45
Correction: Pathology in Practice: presumptive epidermolysis bullosa acquisita in a dog. 61
30938612 2019
46
[Epidermolysis bullosa acquisita]. 61
30887080 2019
47
Ocular Manifestations and Management of Autoimmune Bullous Diseases. 61
31114657 2019
48
Consensus on the treatment of autoimmune bullous dermatoses: bullous pemphigoid, mucous membrane pemphigoid and epidermolysis bullosa acquisita - Brazilian Society of Dermatology. 61
31166405 2019
49
Diagnosis of anti-laminin γ-1 pemphigoid by immunoblot analysis. 61
29972879 2019
50
Possible involvement of IgE antibody in epidermolysis bullosa acquisita: detection and correlation. 61
30973335 2019
51
Elevation of serum interleukin-21 in patients with epidermolysis bullosa acquisita. 61
30672610 2019
52
Ocular Mucous Membrane Pemphigoid: Current State of Pathophysiology, Diagnostics and Treatment. 61
30694513 2019
53
Post-orf epidermolysis bullosa acquisita. 61
30357964 2019
54
Detection of u-serrated patterns in direct immunofluorescence images of autoimmune bullous diseases by inhibition-augmented COSFIRE filters. 61
30623781 2019
55
Fcγ Receptor IIB Controls Skin Inflammation in an Active Model of Epidermolysis Bullosa Acquisita. 61
31993051 2019
56
In utero development of epidermolysis bullosa acquisita. 61
30338555 2019
57
High-Dose Intravenous Immunoglobulin in Skin Autoimmune Disease. 61
31244821 2019
58
Milia within resolving bullous pemphigoid lesions. 61
30956594 2019
59
Complement Activation in Autoimmune Bullous Dermatoses: A Comprehensive Review. 61
31293600 2019
60
Direct Immunofluorescence of Mechanobullous Epidermolysis Bullosa Acquisita, Porphyria Cutanea Tarda and Pseudoporphyria. 61
30176039 2019
61
A Case Report of the Use of Rituximab and the Epidermolysis Bullosa Disease Activity Scoring Index (EBDASI) in a Patient with Epidermolysis Bullosa Acquisita with Extensive Esophageal Involvement. 61
30665483 2018
62
Myeloid-Specific Deletion of Mcl-1 Yields Severely Neutropenic Mice That Survive and Breed in Homozygous Form. 61
30464050 2018
63
Bullous autoimmune dermatoses. 61
30395395 2018
64
Steroid-induced Diabetes Complicating Treatment of Epidermolysis Bullosa Acquisita: A Preventable Treatment Complication Stresses the Importance of Primary Care Follow-up. 61
30693161 2018
65
The use of rituximab in treatment of epidermolysis bullosa acquisita: Three new cases and a review of the literature. 61
30284354 2018
66
Brunsting-Perry Type Pemphigoid Causing Secondary Cicatricial Alopecia in 2 Patients. 61
30410903 2018
67
Accessible Diagnostic Methods to Differentiate between Epidermolysis Bullosa Acquisita and Other Subepidermal Autoimmune Bullous Diseases. 61
30210178 2018
68
Meta-analysis of the clinical and immunopathological characteristics and treatment outcomes in epidermolysis bullosa acquisita patients. 61
30180870 2018
69
Neutrophil Adhesion Is a Prerequisite for Antibody-Mediated Proteolytic Tissue Damage in Experimental Models of Epidermolysis Bullosa Acquisita. 61
29559343 2018
70
The International Bullous Diseases Group consensus on diagnostic criteria for epidermolysis bullosa acquisita: a useful tool for dermatologists. 61
30156286 2018
71
International Bullous Diseases Group: consensus on diagnostic criteria for epidermolysis bullosa acquisita. 61
29165796 2018
72
The Value of Type IV Collagen Immunohistochemical Staining in the Differential Diagnosis of Autoimmune Subepidermal Bullous Diseases. 61
29989869 2018
73
Treatment of Autoimmune Bullous Disorders in Pregnancy. 61
29392620 2018
74
Granzyme B is elevated in autoimmune blistering diseases and cleaves key anchoring proteins of the dermal-epidermal junction. 61
29946113 2018
75
Epidermolysis bullosa acquisita in association with mantle cell lymphoma. 61
30063787 2018
76
Epidermal aspects of type VII collagen: Implications for dystrophic epidermolysis bullosa and epidermolysis bullosa acquisita. 61
29352483 2018
77
Case Report of a 21-Year-Old Man With Epidermolysis Bullosa Acquisita. 61
29865955 2018
78
Serration pattern analysis for differentiating epidermolysis bullosa acquisita from other pemphigoid diseases. 61
29154993 2018
79
Epidermolysis Bullosa (EB) Acquisita in an Adult Patient with Previously Unrecognized Mild Dystrophic EB and Biallelic COL7A1 Mutations. 61
29182795 2018
80
Case of epidermolysis bullosa acquisita with concomitant anti-laminin-332 antibodies. 61
29205468 2018
81
Blistering diseases in the mature patient. 61
29566927 2018
82
Discrepancies in the evaluation of incapacity for work in a patient with epidermolysis bullosa acquisita between public pension fund and occupational medicine expert raise the issue of competencies. 61
29604201 2018
83
Response to 'Serological diagnostics in the detection of IgG autoantibodies against human collagen VII in epidermolysis bullosa acquisita: a multicentre analysis': reply from authors. 61
29322498 2018
84
Response to 'Serological diagnostics in the detection of IgG autoantibodies against human collagen VII in epidermolysis bullosa acquisita: a multicentre analysis'. 61
28977674 2018
85
Calcitriol Treatment Ameliorates Inflammation and Blistering in Mouse Models of Epidermolysis Bullosa Acquisita. 61
28942362 2018
86
Orf - a potential trigger for self-limiting epidermolysis bullosa acquisita-like blistering. 61
29441548 2018
87
Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management. 61
28779299 2018
88
Subepidermal autoimmune bullous diseases: overview, epidemiology, and associations. 61
29159697 2018
89
Colchicine: an ancient drug with novel applications. 61
28832953 2018
90
Human orf complicated by epidermolysis bullosa acquisita. 61
28338219 2018
91
Effectiveness and Safety of Rituximab in Recalcitrant Pemphigoid Diseases. 61
29520266 2018
92
Dimethyl fumarate modulates neutrophil extracellular trap formation in a glutathione- and superoxide-dependent manner. 61
28733990 2018
93
Specific Inhibition of Complement Activation Significantly Ameliorates Autoimmune Blistering Disease in Mice. 61
29616034 2018
94
The Autoimmune Skin Disease Bullous Pemphigoid: The Role of Mast Cells in Autoantibody-Induced Tissue Injury. 61
29545809 2018
95
Anti-Type VII Collagen Antibodies Are Identified in a Subpopulation of Bullous Pemphigoid Patients With Relapse. 61
29619029 2018
96
Whole-Genome Expression Profiling in Skin Reveals SYK As a Key Regulator of Inflammation in Experimental Epidermolysis Bullosa Acquisita. 61
29497423 2018
97
Therapeutic Effect of a Novel Phosphatidylinositol-3-Kinase δ Inhibitor in Experimental Epidermolysis Bullosa Acquisita. 61
30050528 2018
98
Epidermolysis Bullosa Acquisita: The 2019 Update. 61
30687710 2018
99
The Immunometabolomic Interface Receptor Hydroxycarboxylic Acid Receptor 2 Mediates the Therapeutic Effects of Dimethyl Fumarate in Autoantibody-Induced Skin Inflammation. 61
30154797 2018
100
Distinguishing Epidermolysis Bullosa Acquisita From Bullous Pemphigoid Without Direct Immunofluorescence. 61
28719980 2018
101
An 81-Year-Old Woman with Recalcitrant Blisters. 61
29719822 2018
102
Nanoparticles prepared from porcine cells support the healing of cutaneous inflammation in mice and wound re-epithelialization in human skin. 61
28940860 2017
103
Epidermolysis bullosa acquisita. 61
29447655 2017
104
Serological diagnostics in the detection of IgG autoantibodies against human collagen VII in epidermolysis bullosa acquisita: a multicentre analysis. 61
28703393 2017
105
Evidence for a contributory role of a xenogeneic immune response in experimental epidermolysis bullosa acquisita. 61
28887841 2017
106
Signalling and targeted therapy of inflammatory cells in epidermolysis bullosa acquisita. 61
28266741 2017
107
CD11b-deficient mice exhibit an increased severity in the late phase of antibody transfer-induced experimental epidermolysis bullosa acquisita. 61
28857285 2017
108
Determining the Incidence of Pneumocystis Pneumonia in Patients With Autoimmune Blistering Diseases Not Receiving Routine Prophylaxis. 61
28854309 2017
109
CCL3/MIP1α represents a biomarker but not a mandatory cytokine for disease development in experimental epidermolysis bullosa acquisita. 61
28711238 2017
110
The Syk Tyrosine Kinase Is Required for Skin Inflammation in an In Vivo Mouse Model of Epidermolysis Bullosa Acquisita. 61
28576735 2017
111
A rare occurrence of epidermolysis bullosa acquisita in a patient with retroviral disease. 61
28632473 2017
112
Efficacy of intravenous immunoglobulins for the treatment of mucous membrane pemphigoid-like epidermolysis bullosa acquisita. 61
29084648 2017
113
Epidermolysis bullosa acquisita and anti-p200 pemphigoid as major subepidermal autoimmune bullous diseases diagnosed by floor binding on indirect immunofluorescence microscopy using human salt-split skin. 61
28749386 2017
114
In vivo enzymatic modulation of IgG antibodies prevents immune complex-dependent skin injury. 61
27512946 2017
115
Epidermolysis Bullosa Acquisita (Brunsting-Perry Pemphigoid Variant) Localized to the Face and Diagnosed With Antigen Identification Using Skin Deficient in Type VII Collagen. 61
28452792 2017
116
Liver Transplant in a Patient With Acquired Epidermolysis Bullosa and Associated End-Stage Liver Disease. 61
26671706 2017
117
Coexistence of psoriasis and epidermolysis bullosa acquisita: Evaluation of the integrity of the basement membrane. 61
28425108 2017
118
The Leukotriene B4 and its Receptor BLT1 Act as Critical Drivers of Neutrophil Recruitment in Murine Bullous Pemphigoid-Like Epidermolysis Bullosa Acquisita. 61
28108297 2017
119
Bullous, pseudobullous, & pustular dermatoses. 61
28108048 2017
120
Topically Applied Hsp90 Blocker 17AAG Inhibits Autoantibody-Mediated Blister-Inducing Cutaneous Inflammation. 61
27659253 2017
121
Childhood epidermolysis bullosa acquisita during squaric acid dibutyl ester immunotherapy for alopecia areata. 61
27208509 2017
122
Clinical features and diagnosis of epidermolysis bullosa acquisita. 61
27580464 2017
123
Reduced skin blistering in experimental epidermolysis bullosa acquisita after anti-TNF treatment. 61
27999842 2017
124
Long-term results of rituximab-intravenous immunoglobulin combination therapy in patients with epidermolysis bullosa acquisita resistant to conventional therapy. 61
27161164 2017
125
Usefulness of a Simple Immunohistochemical Staining Technique to Differentiate Anti-p200 Pemphigoid From Other Autoimmune Blistering Diseases: A Report of 2 Cases. 61
27095685 2017
126
Acute renal failure in a patient with epidermolysis bullosa acquisita. 61
29267434 2017
127
Research Techniques Made Simple: Mouse Models of Autoimmune Blistering Diseases. 61
28010761 2017
128
Coexistence of acquired hemophilia A and epidermolysis bullosa acquisita: Two case reports and published work review. 61
27511892 2017
129
Evaluation of Autoimmune Bullous Diseases in Elderly Patients in Iran: A 10-Year Retrospective Study. 61
28705276 2017
130
T cells mediate autoantibody-induced cutaneous inflammation and blistering in epidermolysis bullosa acquisita. 61
27917914 2016
131
PDE4 Inhibition as Potential Treatment of Epidermolysis Bullosa Acquisita. 61
27388992 2016
132
Epidermolysis bullosa acquisita associated with dysphagia and stricture of esophagus. 61
27643544 2016
133
Oral colchicine monotherapy for epidermolysis bullosa acquisita: Mechanism of action and efficacy. 61
27153772 2016
134
An autoimmune bullous dermatosis with clinical, histopathological and immunological features of bullous pemphigoid and epidermolysis bullosa acquisita in an adult. 61
26989994 2016
135
Autoimmune Blistering Diseases in the Elderly: Clinical Presentations and Management. 61
27738963 2016
136
[Involvement of mucous membranes in autoimmune bullous diseases]. 61
27631412 2016
137
Inzidenz von bullösen Autoimmunerkrankungen in Serbien: eine retrospektive Studie über 20 Jahre. 61
27767269 2016
138
Incidence of autoimmune bullous diseases in Serbia: a 20-year retrospective study. 61
27767273 2016
139
Diffuse Bullous Eruptions in an Elderly Woman: Late-Onset Bullous Systemic Lupus Erythematosus. 61
27920678 2016
140
Discovering potential drug-targets for personalized treatment of autoimmune disorders - what we learn from epidermolysis bullosa acquisita. 61
26838687 2016
141
Laboratory Diagnosis and Clinical Profile of Anti-p200 Pemphigoid. 61
27167149 2016
142
Clinical and immunological studies for 105 Japanese seropositive patients of epidermolysis bullosa acquisita examined at Kurume University. 61
27247994 2016
143
Cytoskeletal Regulation of Inflammation and Its Impact on Skin Blistering Disease Epidermolysis Bullosa Acquisita. 61
27420054 2016
144
Neonatal Autoimmune Blistering Disease: A Systematic Review. 61
27086740 2016
145
Comparison of 3 type VII collagen (C7) assays for serologic diagnosis of epidermolysis bullosa acquisita (EBA). 61
26947449 2016
146
The use of Biochip immunofluorescence microscopy for the serological diagnosis of epidermolysis bullosa acquisita. 61
26895535 2016
147
Clinical, demographic and immunopathological spectrum of subepidermal autoimmune bullous diseases at a tertiary center: A 1-year audit. 61
27088957 2016
148
Childhood Epidermolysis Bullosa Acquisita: Confirmation of Diagnosis by Skin Deficient in Type VII Collagen, Enzyme-linked Immunosorbent Assay, and Immunoblotting. 61
27293257 2016
149
Skin microbiota-associated inflammation precedes autoantibody induced tissue damage in experimental epidermolysis bullosa acquisita. 61
26341384 2016
150
Chemical shift assignments of the fibronectin III like domains 7-8 of type VII collagen. 61
26364055 2016
151
Myeloid-related proteins-8 and -14 are expressed but dispensable in the pathogenesis of experimental epidermolysis bullosa acquisita and bullous pemphigoid. 61
26692467 2016
152
Paraneoplastic Epidermolysis Bullosa Acquisita Associated with Thyroid Carcinoma. 61
26303980 2016
153
Epidermolysis Bullosa Acquisita Develops in Dominant Dystrophic Epidermolysis Bullosa. 61
26763454 2016
154
Utility of Direct Immunofluorescence Studies in Subclassification of Autoimmune Sub-Epidermal Bullous Diseases: A 2-Year Study in a Tertiary Care Hospital. 61
27136107 2016
155
Diagnostic performance of the "MESACUP anti-Skin profile TEST". 61
26771500 2016
156
Dimethylfumarate Impairs Neutrophil Functions. 61
26763431 2016
157
Epidermolysis Bullosa Acquisita: From Pathophysiology to Novel Therapeutic Options. 61
26763420 2016
158
A Case of Bullous Skin Disease Presenting with Odynophagia: A Diagnostic Challenge. 61
27066279 2016
159
IgM-type epidermolysis bullosa acquisita. 61
26285920 2015
160
Canine epidermolysis bullosa acquisita: a retrospective study of 20 cases. 61
26369402 2015
161
A case of bullous scabies misdiagnosed as acquired epidermolysis bullosa. 61
26227008 2015
162
Inflammatory epidermolysis bullosa acquisita in a 4-year-old girl. 61
26046385 2015
163
Childhood epidermolysis bullosa acquisita with underlying coeliac disease. 61
25824338 2015
164
Dimethylfumarate Impairs Neutrophil Functions. 61
26436330 2015
165
Heat shock protein 90 inhibition: A potential double- or triple-edged sword in the treatment of mucous membrane pemphigoid. 61
26152650 2015
166
Radiosensitive Hematopoietic Cells Determine the Extent of Skin Inflammation in Experimental Epidermolysis Bullosa Acquisita. 61
26202985 2015
167
The retinoid-related orphan receptor alpha is essential for the end-stage effector phase of experimental epidermolysis bullosa acquisita. 61
25953430 2015
168
Reliability of the autoimmune bullous disease quality of life (ABQOL) questionnaire in the USA. 61
25795375 2015
169
Epidermolysis Bullosa Acquisita Develops in Dominant Dystrophic Epidermolysis Bullosa. 61
26401585 2015
170
Epidermolysis bullosa acquisita in a patient with psoriasis vulgaris. 61
26243636 2015
171
Mycophenolate mofetil (MMF) in the treatment of epidermolysis bullosa acquisita (EBA) long-term follow-up. 61
27051767 2015
172
A childhood subepidermal autoimmune bullous disease resembling mechanobullous epidermolysis bullosa acquisita. 61
25865032 2015
173
[Expression of transient receptor potential lvanilloidreceptor 4 protein in autoimmune bullous skin disorders]. 61
26403753 2015
174
Heat shock protein 90: a pathophysiological factor and novel treatment target in autoimmune bullous skin diseases. 61
25980533 2015
175
Epidermolysis bullosa acquisita in a 17-year-old boy with Crohn's disease. 61
26163555 2015
176
Autoantibodies to Multiple Epitopes on the Non-Collagenous-1 Domain of Type VII Collagen Induce Blisters. 61
25689103 2015
177
Heat shock protein 90 is required for ex vivo neutrophil-driven autoantibody-induced tissue damage in experimental epidermolysis bullosa acquisita. 61
25739426 2015
178
Erythrodermic Epidermolysis Bullosa Acquisita. 61
25785509 2015
179
Epidermolysis bullosa acquisita of MRSA skin carrier: a case of successful total hip arthroplasty. 61
25952910 2015
180
Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome associated with neonatal epidermolysis bullosa acquisita. 61
25790289 2015
181
Conditional depletion of mast cells has no impact on the severity of experimental epidermolysis bullosa acquisita. 61
25678008 2015
182
Porphyria Cutanea Tarda Masquerading as Epidermolysis Bullosa Acquisita: A Report of Two Cases. 61
26269702 2015
183
Caspase-1-independent IL-1 release mediates blister formation in autoantibody-induced tissue injury through modulation of endothelial adhesion molecules. 61
25795756 2015
184
Recombinant soluble CD32 suppresses disease progression in experimental epidermolysis bullosa acquisita. 61
25330298 2015
185
Effects of intravenous immunoglobulins on mice with experimental epidermolysis bullosa acquisita. 61
25330299 2015
186
The successful use of extracorporeal photopheresis in a 12-year-old patient with refractory epidermolysis bullosa acquisita. 61
25639865 2015
187
Epidermolysis bullosa and the partnership with autoimmunity: what should we assimilate? 61
25412732 2015
188
Animal models to investigate pathomechanisms and evaluate novel treatments for autoimmune bullous dermatoses. 61
25777758 2015
189
Immune mechanism-targeted treatment of experimental epidermolysis bullosa acquisita. 61
26471717 2015
190
Oesophageal involvement in epidermolysis bullosa acquisita. 61
24975454 2015
191
[Generalized inflammatory epidermolysis bullosa acquisita initially diagnosed as viral exanthem: a rare disease within the subepidermal blistering disorders]. 61
25260302 2014
192
Bullous systemic lupus erythematosus: a review and update to diagnosis and treatment. 61
25358414 2014
193
Epidermolysis bullosa acquisita-like eruption with anticollagen VII autoantibodies induced by D-penicillamine in Wilson disease. 61
24888462 2014
194
Epidermolysis bullosa acquisita: a retrospective analysis of 12 patients evaluated in four tertiary hospitals in Spain. 61
24890437 2014
195
Immunofluorescence testing in the diagnosis of autoimmune blistering diseases: overview of 10-year experience. 61
25387492 2014
196
Refractory bullous pemphigoid leaving numerous milia during recovery. 61
25346302 2014
197
Inflammatory epidermolysis bullosa acquisita effectively treated with minocycline. 61
24577587 2014
198
Blister-inducing antibodies target multiple epitopes on collagen VII in mice. 61
25091020 2014
199
Fcγ receptors III and IV mediate tissue destruction in a novel adult mouse model of bullous pemphigoid. 61
25043618 2014
200
Immunomodulatory effects of heat shock protein 90 inhibition on humoral immune responses. 61
24961936 2014
201
Recombinant human IgA1 and IgA2 autoantibodies to type VII collagen induce subepidermal blistering ex vivo. 61
25024393 2014
202
Peristomal epidermolysis bullosa acquisita in a patient with Crohn's disease. 61
24322876 2014
203
Anti-p200 pemphigoid. 61
24767733 2014
204
Treatment of severe autoimmune blistering skin diseases with combination of protein A immunoadsorption and rituximab: a protocol without initial high dose or pulse steroid medication. 61
23651052 2014
205
Autoimmune blistering dermatoses as systemic diseases. 61
24767184 2014
206
[Epidermolysa bullosa acquisita and graft-versus-host disease]. 61
24835650 2014
207
Sensitivity of different assays for the serological diagnosis of epidermolysis bullosa acquisita: analysis of a cohort of 24 Italian patients. 61
24321031 2014
208
A case of recalcitrant epidermolysis bullosa acquisita responsive to rituximab therapy. 61
23106762 2014
209
Hair loss in autoimmune systemic diseases. 61
24566567 2014
210
EndoS reduces the pathogenicity of anti-mCOL7 IgG through reduced binding of immune complexes to neutrophils. 61
24504190 2014
211
GM-CSF modulates autoantibody production and skin blistering in experimental epidermolysis bullosa acquisita. 61
24337383 2014
212
Retrospective study of the clinical, histologic, and immunologic features of epidermolysis bullosa acquisita in 9 patients. 61
23895729 2013
213
Anti-type VII collagen autoantibodies, detected by enzyme-linked immunosorbent assay, fluctuate in parallel with clinical severity in patients with epidermolysis bullosa acquisita. 61
24127822 2013
214
Methylprednisolone blocks autoantibody-induced tissue damage in experimental models of bullous pemphigoid and epidermolysis bullosa acquisita through inhibition of neutrophil activation. 61
23448878 2013
215
Epidermolysis bullosa acquisita. 61
23368767 2013
216
B cells, dendritic cells, and macrophages are required to induce an autoreactive CD4 helper T cell response in experimental epidermolysis bullosa acquisita. 61
23960233 2013
217
The n- vs. u-serration is a learnable criterion to differentiate pemphigoid from epidermolysis bullosa acquisita in direct immunofluorescence serration pattern analysis. 61
23489262 2013
218
IgG autoantibody subclass analysis as a tool to differentiate epidermolysis bullosa acquisita with overlapping features of bullous systemic lupus erythematosus. 61
23768307 2013
219
Low sensitivity of type VII collagen enzyme-linked immunosorbent assay in epidermolysis bullosa acquisita: serration pattern analysis on skin biopsy is required for diagnosis. 61
23480491 2013
220
Metabolite analysis distinguishes between mice with epidermolysis bullosa acquisita and healthy mice. 61
23800341 2013
221
Childhood epidermolysis bullosa acquisita associated with severe dental alterations: a case presentation. 61
23442118 2013
222
Topically applied flightless I neutralizing antibodies improve healing of blistered skin in a murine model of epidermolysis bullosa acquisita. 61
23223144 2013
223
Epidermolysis bullosa acquisita and inflammatory bowel disease: a review of the literature. 61
23517353 2013
224
Images in clinical medicine. Epidermolysis bullosa acquisita. 61
23534583 2013
225
Sensitive and specific assays for routine serological diagnosis of epidermolysis bullosa acquisita. 61
22341608 2013
226
Fluorescence overlay antigen mapping using laser scanning confocal microscopy differentiates linear IgA bullous dermatosis from epidermolysis bullosa acquisita mediated by IgA. 61
22924407 2013
227
Serum levels of anti-type VII collagen antibodies detected by enzyme-linked immunosorbent assay in patients with epidermolysis bullosa acquisita are correlated with the severity of skin lesions. 61
22731917 2013
228
Cutaneous manifestations of gastrointestinal disease: part II. 61
23317981 2013
229
Recombinant IL-6 treatment protects mice from organ specific autoimmune disease by IL-6 classical signalling-dependent IL-1ra induction. 61
22980031 2013
230
Clinical presentation, pathogenesis, diagnosis, and treatment of epidermolysis bullosa acquisita. 61
23956869 2013
231
Induction of experimental epidermolysis bullosa acquisita by immunization with murine collagen VII. 61
23325658 2013
232
Aberrant expression and secretion of heat shock protein 90 in patients with bullous pemphigoid. 61
23936217 2013
233
Diagnosis and disease severity assessment of epidermolysis bullosa acquisita by ELISA for anti-type VII collagen autoantibodies: an Italian multicentre study. 61
22913489 2013
234
Persistent autoantibody-production by intermediates between short-and long-lived plasma cells in inflamed lymph nodes of experimental epidermolysis bullosa acquisita. 61
24386241 2013
235
The vWFA2 domain of type VII collagen is responsible for collagen binding. 61
23237810 2013
236
Genome-wide mapping of gene-microbiota interactions in susceptibility to autoimmune skin blistering. 61
24042968 2013
237
Bullous pemphigoid with prominent milium formation. 61
23683484 2013
238
Evidence for pathogenicity of autoreactive T cells in autoimmune bullous diseases shown by animal disease models. 61
23016514 2012
239
Time-course of the change in titre of antibodies against type VII collagen in a patient with epidermolysis bullosa acquisita. 61
22434144 2012
240
Long-term efficacy of extracorporeal photochemotherapy in a patient with refractory epidermolysis bullosa acquisita. 61
23228865 2012
241
Granulocyte-dependent autoantibody-induced skin blistering. 61
23092942 2012
242
Genetic identification and functional validation of FcγRIV as key molecule in autoantibody-induced tissue injury. 61
22430937 2012
243
Pathogenesis of epidermolysis bullosa acquisita, an autoimmune subepidermal bullous disease. 61
22692770 2012
244
Childhood epidermolysis bullosa acquisita: report of a Chinese case. 61
21966900 2012
245
Treatment of epidermolysis bullosa acquisita with intravenous immunoglobulin in patients non-responsive to conventional therapy: clinical outcome and post-treatment long-term follow-up. 61
21819451 2012
246
Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcγRIIB and dectin-1. 61
22922409 2012
247
Identification of quantitative trait loci in experimental epidermolysis bullosa acquisita. 61
22297639 2012
248
Successful treatment of epidermolysis bullosa acquisita with rituximab therapy. 61
22611565 2012
249
Epidermolysis bullosa acquisita: a rare challenge in dental management. 61
22536657 2012
250
Prevalence of collagen VII-specific autoantibodies in patients with autoimmune and inflammatory diseases. 61
22471736 2012
251
Epidermolysis bullosa acquisita: autoimmunity to anchoring fibril collagen. 61
21955050 2012
252
Intravenous immunoglobulin in the treatment of autoimmune bullous dermatoses: an update. 61
21923613 2012
253
Model systems duplicating epidermolysis bullosa acquisita: a methodological review. 61
21923614 2012
254
Detection of collagen VII autoantibodies to NC1 and NC2 domains of collagen VII by ELISA in suspected epidermolysis bullosa acquisita and bullous lupus erythematosus patients. 61
22225828 2012
255
A case of epidermolysis bullosa acquisita associated with laryngeal stenosis. 61
22215014 2012
256
Management of cutaneous disorders related to inflammatory bowel disease. 61
24713996 2012
257
Collagen IV in Normal Skin and in Pathological Processes. 61
22393540 2012
258
Epidermolysis bullosa acquisita. 61
22137228 2012
259
Autoimmune bullous diseases associations. 61
22137223 2012
260
Autoimmune blistering diseases of the skin. 61
21640850 2012
261
Treatment of subepidermal immunobullous diseases. 61
22137232 2012
262
Immunosuppressive therapy for autoimmune bullous diseases. 61
22137230 2012
263
Spectrum of autoimmune bullous diseases in Iran: a 10-year review. 61
22182376 2012
264
Black patients of African descent and HLA-DRB1*15:03 frequency overrepresented in epidermolysis bullosa acquisita. 61
21833018 2011
265
Complement-fixing anti-type VII collagen antibodies are induced in Th1-polarized lymph nodes of epidermolysis bullosa acquisita-susceptible mice. 61
21967893 2011
266
Accuracy of indirect immunofluorescence on sodium chloride-split skin in the differential diagnosis of bullous pemphigoid and epidermolysis bullosa acquisita. 61
22016274 2011
267
Overexpression of the Flii gene increases dermal-epidermal blistering in an autoimmune ColVII mouse model of epidermolysis bullosa acquisita. 61
21984127 2011
268
Autoimmune bullous skin diseases. Part 1: Clinical manifestations. 61
21955378 2011
269
Immunofluorescence serration pattern analysis as a diagnostic criterion in antilaminin-332 mucous membrane pemphigoid: immunopathological findings and clinical experience in 10 Dutch patients. 61
21692774 2011
270
Bullous systemic lupus erythematosus. 61
21925012 2011
271
Management of epidermolysis bullosa acquisita. 61
21925011 2011
272
Epidermolysis bullosa acquisita: current diagnosis and therapy. 61
25386290 2011
273
Heterogeneity of Brunsting-Perry type pemphigoid: a case showing blister formation at the lamina lucida, immune deposition beneath the lamina densa and autoantibodies against the 290-kD polypeptide along the lamina densa. 61
21366683 2011
274
Could cytomegalovirus infection play a causative role in epidermolysis bullosa acquisita? 61
21659069 2011
275
[Epidermolysis bullosa acquisita complicated by esophageal stenosis. Endoscopic treatment with thermoplastic dilators and intralesional steroid injection]. 61
22041322 2011
276
Diagnosis and clinical features of epidermolysis bullosa acquisita. 61
21605816 2011
277
Evidence-based treatments for pemphigus vulgaris, pemphigus foliaceus, and bullous pemphigoid: a systematic review. 61
21727693 2011
278
Rituximab for patients with refractory mucous membrane pemphigoid. 61
21422323 2011
279
Pathogenesis of epidermolysis bullosa acquisita. 61
21605817 2011
280
Molecular organization of the basement membrane zone. 61
21679867 2011
281
The many faces of epidermolysis bullosa acquisita after serration pattern analysis by direct immunofluorescence microscopy. 61
21457208 2011
282
Nail involvement in autoimmune bullous disorders. 61
21605819 2011
283
Development of NC1 and NC2 domains of type VII collagen ELISA for the diagnosis and analysis of the time course of epidermolysis bullosa acquisita patients. 61
21482078 2011
284
The diagnosis and treatment of autoimmune blistering skin diseases. 61
21712975 2011
285
Heat-shock protein 90 inhibition in autoimmunity to type VII collagen: evidence that nonmalignant plasma cells are not therapeutic targets. 61
21490339 2011
286
Current concepts in the treatment of epidermolysis bullosa acquisita. 61
21254861 2011
287
Autoantibody-induced intestinal inflammation and weight loss in experimental epidermolysis bullosa acquisita. 61
21381035 2011
288
Epidermolysis bullosa acquisita: a retrospective clinical analysis of 30 cases. 61
21394418 2011
289
Autoreactivity to bullous pemphigoid 180: is this the link between subepidermal blistering diseases and oral lichen planus? 61
20569254 2011
290
Sustained clinical response to rituximab in a case of life-threatening overlap subepidermal autoimmune blistering disease. 61
20494477 2011
291
False-positive intercellular indirect immunofluorescence test due to anti-blood group antibodies in a patient with epidermolysis bullosa acquisita. 61
21413961 2011
292
Epidermolysis bullosa acquisita with moderately severe Dysphagia due to esophageal strictures. 61
21716557 2011
293
[Epidermolysis bullosa acquisita. Guidelines for the diagnosis and treatment. Centres de référence des maladies bulleuses auto-immunes. Société Française de Dermatologie]. 61
21397160 2011
294
Enzyme-linked immunosorbent assay for the combination of bullous pemphigoid antigens 1 and 2 in the diagnosis of bullous pemphigoid. 61
21422336 2011
295
[Epidermolysis bullosa acquisita: literature review]. 61
21397153 2011
296
Congenital epidermolysis bullosa acquisita: vertical transfer of maternal autoantibody from mother to infant. 61
21079052 2011
297
Development of a simple enzyme-linked immunosorbent assay for the detection of autoantibodies in anti-p200 pemphigoid. 61
20854435 2011
298
Generation of antibodies of distinct subclasses and specificity is linked to H2s in an active mouse model of epidermolysis bullosa acquisita. 61
20720563 2011
299
Clinical and immunopathological evaluation of epidermolysis bullosa acquisita. 61
20456382 2011
300
Autoimmune blistering diseases in the elderly. 61
21146735 2011
301
Remission of severe autoimmune bullous disorders induced by long-term extracorporeal photochemotherapy. 61
21035398 2010
302
[Epidermolysis bullosa acquisita]. 61
20674256 2010
303
Autoimmunity against type VII collagen in inflammatory bowel disease. 61
19878366 2010
304
Widespread vesiculobullous eruption in a 16-year-old male. 61
20976416 2010
305
Salt split technique: a useful tool in the diagnosis of subepidermal bullous disorders. 61
21430884 2010
306
[Autoimmune bullous skin disorders]. 61
20806175 2010
307
Clinical and immunological heterogeneity of canine subepidermal blistering dermatoses with anti-laminin-332 (laminin-5) auto-antibodies. 61
20456722 2010
308
Immune reactivity to type VII collagen: implications for gene therapy of recessive dystrophic epidermolysis bullosa. 61
20376098 2010
309
Severe acral contractures and nail loss in a patient with mechano-bullous Epidermolysis bullosa acquisita. 61
20522419 2010
310
Oral mucosal diseases: the inflammatory dermatoses. 61
20553242 2010
311
[Acute pseudo-membranous laryngitis in epidermolysis bullosa acquisita]. 61
20413194 2010
312
Epidermolysis bullosa acquisita associated with psoriasis. 61
20526561 2010
313
Immunoadsorption in dermatology. 61
20049466 2010
314
Immunomodulatory therapy to achieve maximum efficacy: doses, monitoring, compliance, and self-infusion at home. 61
20387103 2010
315
Basement membrane antibodies in sera of haematopoietic cell recipients are associated with graft-versus-host disease. 61
19906045 2010
316
Usefulness of collagen IV immunostaining for diagnosis of canine epidermolysis bullosa acquisita. 61
20375426 2010
317
Clearance rates of circulating and tissue-bound autoantibodies to type VII collagen in experimental epidermolysis bullosa acquisita. 61
20222918 2010
318
T and B cells target identical regions of the non-collagenous domain 1 of type VII collagen in epidermolysis bullosa acquisita. 61
20093095 2010
319
Cross-reactivity of autoantibodies from patients with epidermolysis bullosa acquisita with murine collagen VII. 61
20084423 2010
320
Place of human amniotic membrane immunoblotting in the diagnosis of autoimmune bullous dermatoses. 61
19886889 2010
321
Epidermolysis bullosa acquisita: what's new? 61
20507385 2010
322
Metal sensitization precipitates skin blistering in epidermolysis bullosa acquisita. 61
20507396 2010
323
From anti-p200 pemphigoid to anti-laminin gamma1 pemphigoid. 61
20507386 2010
324
T cells are required for the production of blister-inducing autoantibodies in experimental epidermolysis bullosa acquisita. 61
20038644 2010
325
Premonitory epidermolysis bullosa acquisita mimicking eyelid dermatitis: successful treatment with rituximab and protein A immunoapheresis. 61
20373827 2010
326
Autoimmune bullous dermatoses in the elderly: an update on pathophysiology, diagnosis and management. 61
20030429 2010
327
A patient with multiple blisters in the skin and mucous membranes. 61
22242049 2010
328
Type VII collagen: the anchoring fibril protein at fault in dystrophic epidermolysis bullosa. 61
19945621 2010
329
Inflammatory epidermolysis bullosa acquisita mimicking toxic epidermal necrolysis and dermatitis herpetiformis. 61
19663858 2009
330
[Infective endocarditis in a dermatology unit]. 61
20004311 2009
331
A case of epidermolysis bullosa acquisita with unusual clinical features. 61
19817767 2009
332
Current treatment of autoimmune blistering diseases. 61
20025595 2009
333
Refractory epidermolysis bullosa acquisita: successful treatment with rituximab. 61
20055876 2009
334
[Orogenital and conjunctival involvement in hereditary and autoimmune blistering diseases]. 61
19855943 2009
335
[Successful use of combined corticosteroids and rituximab in the treatment of recalcitrant epidermolysis bullosa acquisita]. 61
19917432 2009
336
A case of epidermolysis bullosa acquisita with clinical features of Brunsting-Perry pemphigoid showing an excellent response to colchicine. 61
19679376 2009
337
Mixed immunobullous disorder most consistent with the IgA-form of epidermolysis bullosa acquisita. 61
19891927 2009
338
Rituximab in dermatological diseases. 61
19755955 2009
339
[Optimizing therapy in patients with severe autoimmune blistering skin diseases]. 61
19536513 2009
340
[Epidermolysis bullosa acquisita of childhood]. 61
19560612 2009
341
Some epidermolysis bullosa acquisita sera react with epitopes within the triple-helical collagenous domain as indicated by immunoelectron microscopy. 61
19067699 2009
342
Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany. 61
19170813 2009
343
Periorbital papulovesicular eruption in an elderly man. Localized periorbital epidermolysis bullosa acquisita (EBA). 61
19451507 2009
344
Research in practice: diagnosis of subepidermal autoimmune bullous disorders. 61
19192160 2009
345
Inflammatory epidermolysis bullosa acquisita: case report. 61
19503987 2009
346
Epidermolysis bullosa acquisita: concise review and practical considerations. 61
19261008 2009
347
Effectiveness and side effects of anti-CD20 therapy for autoantibody-mediated blistering skin diseases: A comprehensive survey of 71 consecutive patients from the Initial use to 2007. 61
19436603 2009
348
Epidermolysis bullosa acquisita in an 18-year-old African-American male: a case report. 61
19582968 2009
349
Subcutaneous immunoglobulin therapy for immunomodulation in a patient with severe epidermolysis bullosa acquisita. 61
18848500 2008
350
Familial epidermolysis bullosa acquisita. 61
19265615 2008
351
Epidermolysis bullosa acquisita requiring multiple oesophageal dilatations. 61
18627393 2008
352
Neonatal Fc receptor deficiency protects from tissue injury in experimental epidermolysis bullosa acquisita. 61
18542899 2008
353
A quick and simple serum test to differentiate bullous pemphigoid, epidermolysis bullosa acquisita, and anti-epiligrin cicatricial pemphigoid. 61
18718187 2008
354
Crohn's disease, relapsing polychondritis and epidermolysis bullosa acquisita: an immune-mediated inflammatory syndrome. 61
18238795 2008
355
Binding of avian IgY to type VII collagen does not activate complement and leucocytes and fails to induce subepidermal blistering in mice. 61
18205879 2008
356
Epidermolysis bullosa acquisita in a Great Dane. 61
17784932 2008
357
Rituximab in treatment-resistant autoimmune blistering skin disorders. 61
18270859 2008
358
Ocular manifestations of blistering diseases. 61
18282549 2008
359
Autoimmunity to type VII collagen: epidermolysis bullosa acquisita. 61
18460887 2008
360
Orf-induced immunobullous disease: A distinct autoimmune blistering disorder. 61
17919774 2008
361
Autoimmunity to type VII collagen: epidermolysis bullosa acquisita. 61
18058258 2007
362
Epidermolysis bullosa acquisita and neuroendocrine pancreatic cancer - Coincidence or patho-genetic relationship? 61
17910674 2007
363
Epidermolysis bullosa acquisita associated with psoriasis vulgaris. 61
17459071 2007
364
Dermal-binding linear IgA disease: an uncommon subset of a rare immunobullous disease. 61
17459072 2007
365
Fatal Pseudomona pneumonia following rituximab therapy in a patient with epidermolysis bullosa acquisita. 61
17714160 2007
366
Treatment-resistant classical epidermolysis bullosa acquisita responding to rituximab. 61
17596155 2007
367
What's new in blistering disorders? 61
17547846 2007
368
High-dose intravenous immunoglobulins for the treatment of autoimmune mucocutaneous blistering diseases: evaluation of its use in 19 cases. 61
17368865 2007
369
Experimental models of epidermolysis bullosa acquisita. 61
17518993 2007
370
NADPH oxidase is required for neutrophil-dependent autoantibody-induced tissue damage. 61
17380558 2007
371
The alternative pathway of complement activation is critical for blister induction in experimental epidermolysis bullosa acquisita. 61
17475881 2007
372
Dermatologic complications after liver transplantation: a single-center experience. 61
17524929 2007
373
Immunopathology and molecular diagnosis of autoimmune bullous diseases. 61
17521373 2007
374
Two patients with localized epidermolysis bullosa acquisita: diagnostic value of laser scanning confocal microscopy. 61
17355235 2007
375
Blindness due to the IgA variant of epidermolysis bullosa acquisita, and treatment with osteo-odonto-keratoprosthesis. 61
17493079 2007
376
[Bullous pemphigoid and acquired hemophilia]. 61
17483755 2007
377
Erythema gyratum repens-like eruption in a patient with epidermolysis bullosa acquisita associated with ulcerative colitis. 61
17263799 2007
378
Case of concurrent epidermolysis bullosa acquisita and anti-p200 pemphigoid--how to treat it? 61
17343589 2007
379
Clinical response of severe mechanobullous epidermolysis bullosa acquisita to combined treatment with immunoadsorption and rituximab (anti-CD20 monoclonal antibodies). 61
17309999 2007
380
A successful therapeutic trial of rituximab in the treatment of a patient with recalcitrant, high-titre epidermolysis bullosa acquisita. 61
17199602 2007
381
Epidermolysis bullosa acquisita following bullous pemphigoid, successfully treated with the anti-CD20 monoclonal antibody rituximab. 61
17823525 2007
382
Epidermolysis bullosa acquisita. 61
17511948 2007
383
Ocular involvement in anti-epiligrin cicatricial pemphigoid. 61
17191196 2006
384
Chronic cicatrizing conjunctivitis in a patient with epidermolysis bullosa acquisita. 61
17102010 2006
385
Childhood epidermolysis bullosa acquisita with autoantibodies against the noncollagenous 1 and 2 domains of type VII collagen: case report and review of the literature. 61
17034540 2006
386
Induction of complement-fixing autoantibodies against type VII collagen results in subepidermal blistering in mice. 61
16920988 2006
387
Canadian consensus statement on the use of intravenous immunoglobulin therapy in dermatology. 61
17234104 2006
388
Autoimmunity to type VII collagen in SKH1 mice is independent of regulatory T cells. 61
16879253 2006
389
Paraneoplastic epidermolysis bullosa acquisita associated with multiple myeloma. 61
16927739 2006
390
Rituximab in refractory autoimmune bullous diseases. 61
16716150 2006
391
Induction of epidermolysis bullosa acquisita in mice by passive transfer of autoantibodies from patients. 61
16543893 2006
392
Epidermolysis bullosa acquisita occurring in 2 patients with hepatitis C. 61
16635676 2006
393
Childhood IgA-mediated epidermolysis bullosa acquisita responding to mycophenolate mofetil as a corticosteroid-sparing agent. 61
16546607 2006
394
Successful adjuvant treatment of recalcitrant epidermolysis bullosa acquisita with anti-CD20 antibody rituximab. 61
16490841 2006
395
Epidermolysis bullosa acquisita: diagnosis by fluorescence overlay antigen mapping and clinical response to high-dose intravenous immunoglobulin. 61
16309488 2006
396
Epidermolysis bullosa acquisita. 61
16481730 2006
397
A case of epidermolysis bullosa acquisita with autoantibody to anti-p200 pemphigoid antigen and exfoliative esophagitis. 61
16707891 2006
398
Treatment of refractory blistering autoimmune diseases with mycophenolic acid. 61
17853312 2006
399
Alterations of basement membrane zone in autoimmune subepidermal bullous diseases. 61
15990279 2005
400
Inflammatory epidermolysis bullosa acquisita with coexistent IgA antibodies to plectin. 61
16045687 2005
401
Cyclosporine controls epidermolysis bullosa acquisita co-occurring with acquired factor VIII deficiency. 61
16101876 2005
402
Evidence that anti-type VII collagen antibodies are pathogenic and responsible for the clinical, histological, and immunological features of epidermolysis bullosa acquisita. 61
15854036 2005
403
The pathophysiology of autoimmune blistering diseases. 61
15841169 2005
404
Induction of dermal-epidermal separation in mice by passive transfer of antibodies specific to type VII collagen. 61
15841176 2005
405
Epidermolysis bullosa acquisita in a child: an additional case. 61
15807745 2005
406
Squamous cell carcinoma arising on scars of epidermolysis bullosa acquisita. 61
15787846 2005
407
Remission of recalcitrant epidermolysis bullosa acquisita (EBA) with colchicine monotherapy. 61
15906541 2005
408
Autoimmune bullous diseases: ocular manifestations and management. 61
16114976 2005
409
Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid. 61
15538734 2004
410
Spectrum of autoimmune bullous diseases in Kuwait. 61
15569006 2004
411
Epidermolysis bullosa acquisita and Crohn's disease. 61
15573217 2004
412
[Mucosal epidermolysis bullosa acquisita complicated by laryngeal stenosis]. 61
15351868 2004
413
A case of epidermolysis bullosa acquisita with bleeding tendency due to factor VIII inhibitor (acquired haemophilia). 61
15377371 2004
414
U-serrated immunodeposition pattern differentiates type VII collagen targeting bullous diseases from other subepidermal bullous autoimmune diseases. 61
15270879 2004
415
A patient with both bullous pemphigoid and epidermolysis bullosa acquisita: an example of intermolecular epitope spreading. 61
15243536 2004
416
Paraneoplastic immunobullous disease with an epidermolysis bullosa acquisita phenotype: two cases demonstrating remission with treatment of gynaecological malignancy. 61
15068465 2004
417
Epidermolysis bullosa acquisita associated with vitiligo, Graves' disease and nephrotic syndrome. 61
15117374 2004
418
Epidermolysis bullosa acquisita sera react with distinct epitopes on the NC1 and NC2 domains of type VII collagen: study using immunoblotting of domain-specific recombinant proteins and postembedding immunoelectron microscopy. 61
15149495 2004
419
The lupus band: do the autoantibodies target collagen VII? 61
15030334 2004
420
Childhood epidermolysis bullosa acquisita with autoantibodies against all 3 structural domains of type VII collagen. 61
14988700 2004
421
Subepidermal blistering disorders: a clinical and histopathologic review. 61
15095911 2004
422
Bullous systemic lupus erythematosus. 61
15234014 2004
423
Superpotent topical steroid therapy for epidermolysis bullosa acquisita. 61
15316178 2004
424
A case of anti-p200 pemphigoid with autoantibodies against both a novel 200-kD dermal antigen and the 290-kD epidermolysis bullosa acquisita antigen. 61
15316171 2004
425
Epidermolysis bullosa acquisita-like reaction associated with penicillamine therapy for sclerodermatous graft-versus-host disease. 61
14639407 2003
426
A Korean case of anti-p200 pemphigoid. 61
14584115 2003
427
A practical technique for differentiation of subepidermal bullous diseases: localization of in vivo-bound IgG by laser scanning confocal microscopy. 61
12925388 2003
428
The sensitivity and specificity of "caterpillar bodies" in the differential diagnosis of subepidermal blistering disorders. 61
12876485 2003
429
Immunofluorescence studies using skin sections of recessive dystrophic epidermolysis bullosa patients indicated that the antigen of anti-p200 pemphigoid is not a fragment of type VII collagen. 61
12850304 2003
430
Clinicopathological case 1: mucous membrane pemphigoid, epidermolysis bullosa acquisita and linear immunoglobulin A disease. 61
12823323 2003
431
[Recurrent corneal ulcer in a patient with Crohn's disease associated with epidermolysis bullosa acquisita]. 61
12830398 2003
432
Immunomapping of EBA sera to multiple epitopes on collagen VII: further evidence that anchoring fibrils originate and terminate in the lamina densa. 61
12823439 2003
433
A case of anti-p200 pemphigoid clinically mimicking inflammatory epidermolysis bullosa acquisita. 61
12786845 2003
434
Human placental amnion is a novel substrate for detecting autoantibodies in autoimmune bullous diseases by immunoblotting. 61
12786824 2003
435
Anti-epiligrin cicatricial pemphigoid and epidermolysis bullosa acquisita: differentiation by use of indirect immunofluorescence microscopy. 61
12664017 2003
436
Acquired epidermolysis bullosa and Crohn's disease. 61
12665771 2003
437
Epidermolysis bullosa acquisita in childhood. 61
12692360 2003
438
Expression profiles of collagens, HSP47, TGF-beta1, MMPs and TIMPs in epidermolysis bullosa acquisita. 61
12824005 2003
439
Isotype determination of circulating autoantibodies in canine autoimmune subepidermal blistering dermatoses. 61
12603682 2003
440
Interventions for mucous membrane pemphigoid and epidermolysis bullosa acquisita. 61
12535507 2003
441
[Blistering autoimmune diseases of childhood]. 61
12567253 2003
442
Blistering disorders: diagnosis and treatment. 61
14510878 2003
443
Autoimmune bullous dermatoses in the elderly: diagnosis and management. 61
12831291 2003
444
Mycophenolate mofetil in epidermolysis bullosa acquisita. 61
14571084 2003
445
Epidermolysis bullosa acquisita and multiple myeloma. 61
12451384 2002
446
Psoriasis bullosa acquisita. 61
12472542 2002
447
IgM-mediated epidermolysis bullosa acquisita. 61
12374560 2002
448
Spectrum of subepidermal immunobullous disorders seen at the National Skin Centre, Singapore: a 2-year review. 61
12207586 2002
449
Childhood epidermolysis bullosa acquisita: a novel variant with reactivity to all three structural domains of type VII collagen. 61
12207608 2002
450
Autoantibodies to type VII collagen mediate Fcgamma-dependent neutrophil activation and induce dermal-epidermal separation in cryosections of human skin. 61
12107115 2002
451
Bullous systemic lupus erythematosus with milia and calcinosis. 61
12184671 2002
452
Epidermolysis bullosa acquisita in an 8-year-old girl. 61
12220292 2002
453
Bullous lesions in scleroderma. 61
12100687 2002
454
The epidermolysis bullosa acquisita antigen (type VII collagen) is present in human colon and patients with crohn's disease have autoantibodies to type VII collagen. 61
12060403 2002
455
A highly sensitive and simple assay for the detection of circulating autoantibodies against full-length bullous pemphigoid antigen 180. 61
12144811 2002
456
Topical cyclosporin in the treatment of dermatologic diseases. 61
12590870 2002
457
Ultrastructural immunocytochemistry of autoimmune bullous diseases. 61
11982567 2002
458
Drug-induced epidermolysis bullosa acquisita with antibodies to type VII collagen. 61
12004302 2002
459
Interventions for mucous membrane pemphigoid/cicatricial pemphigoid and epidermolysis bullosa acquisita: a systematic literature review. 61
11902989 2002
460
Epidermolysis bullosa acquisita: treatment with intravenous immunoglobulins. 61
11952298 2002
461
Effect of substrate selection on indirect immunofluorescence testing of canine autoimmune subepidermal blistering diseases. 61
11858645 2002
462
Dysphagia in a patient with lupus and review of the literature. 61
12090569 2002
463
[Autoantigens of subepidermal bullous autoimmune dermatoses]. 61
11910857 2001
464
Diagnosing new autoimmune blistering skin diseases of dogs and cats. 61
11793876 2001
465
Epidermolysis bullosa acquisita: update and review. 61
11705680 2001
466
Autoimmune vesicles on the face and neck. A variant of Brunsting-Perry type localized bullous pemphigoid? 61
11701408 2001
467
Epidermolysis bullosa acquisita: correlation of IgE levels with disease activity under successful betamethasone/dapsone combination therapy. 61
11859948 2001
468
Treatment of epidermolysis bullosa acquisita with the humanized anti-Tac mAb daclizumab. 61
11683573 2001
469
New immunomodulating drugs in autoimmune blistering diseases. 61
11705351 2001
470
Epidermolysis bullosa acquisita responsive to dapsone therapy. 61
11907850 2001
471
Laryngeal epidermolysis bullosa acquisita requiring tracheostomy presenting with an acquired factor VIII coagulopathy. 61
11555765 2001
472
[Acquired epidermolysis bullosa with a highly varied clinical picture and successful treatment with mycophenolate mofetil]. 61
11544944 2001
473
Bilateral corneal involvement in epidermolysis bullosa acquisita. 61
11473173 2001
474
The carboxyl terminus of type VII collagen mediates antiparallel dimer formation and constitutes a new antigenic epitope for epidermolysis Bullosa acquisita autoantibodies. 61
11274208 2001
475
Emerging treatment for epidermolysis bullosa acquisita. 61
11312431 2001
476
Epidermolysis bullosa acquisita: clinical manifestations, microscopic findings, and surgical periodontal therapy. A case report. 61
11338310 2001
477
Mixed immunobullous disease of childhood: a good response to antimicrobials. 61
11298535 2001
478
Epidermolysis bullosa acquisita responsive to cyclosporin therapy. 61
11495534 2001
479
A review of high-dose intravenous immunoglobulin (hdIVIg) in the treatment of the autoimmune blistering disorders. 61
11298100 2001
480
Epidermolysis bullosa acquisita treated with basiliximab, an interleukin-2 receptor antibody. 61
11411931 2001
481
Autoantibodies to type VII collagen have heterogeneous subclass and light chain compositions and their complement-activating capacities do not correlate with the inflammatory clinical phenotype. 61
11202231 2000
482
An extract of cultured A431 cells contains major tissue antigens of autoimmune bullous diseases. 61
11069463 2000
483
Eosinophilic spongiosis in association with bullous pemphigoid and chronic lymphocytic leukaemia. 61
10951157 2000
484
Epidermolysis bullosa acquisita associated with relapsing polychondritis: an association with eosinophilia? 61
10916695 2000
485
Autoimmune blistering skin diseases. 61
10830686 2000
486
Rat bladder epithelium: a sensitive substrate for indirect immunofluorescence of bullous pemphigoid. 61
10954206 2000
487
Epidermolysis bullosa acquisita with ultraviolet radiationsensitivity. 61
10735962 2000
488
Epidermolysis bullosa acquisita in a 4-year-old boy. 61
10792814 2000
489
Novel localised variant of canine epidermolysis bullosa acquisita. 61
10718593 2000
490
A subepidermal bullous eruption associated with IgG autoantibodies to a 200 kd dermal antigen: the first case report from the United States. 61
10640922 2000
491
Serum IgA autoantibodies in patients with epidermolysis bullosa acquisita: a high frequency of detection. 61
10681627 2000
492
[Epidermolysis bullosa acquisita]. 61
11269080 2000
493
New and emerging therapies in the treatment of blistering diseases. 61
10626118 2000
494
Autoimmune and inherited subepidermal blistering diseases: advances in the clinic and the laboratory. 61
11094626 2000
495
Circulating autoantibodies to tissue transglutaminase differentiate patients with dermatitis herpetiformis from those with linear IgA disease. 61
10570380 1999
496
Ocular involvement in IgA-epidermolysis bullosa acquisita. 61
10583173 1999
497
Epidermolysis bullosa acquisita in a young female. 61
20921694 1999
498
Treatment of epidermolysis bullosa acquisita with mycophenolate mofetil and autologous keratinocyte grafting. 61
10583185 1999
499
A case of acquired autoimmune bullous disease associated with IgM macroglobulinaemia. 61
10554434 1999
500
[Bullous autoimmune diseases of the oral mucosa]. 61
10604215 1999
501
Immunohistochemical characterization of the basement membrane epitopes in bis(2-chloroethyl) sulfide-induced toxicity in mouse ear skin. 61
10513676 1999
502
[Resistant acquired bullous epidermolysis with severe ocular involvement: the success of extracorporeal photochemotherapy]. 61
10530350 1999
503
Mucosal morbidity in patients with epidermolysis bullosa acquisita. 61
10456345 1999
504
Subepidermal autoimmune bullous skin diseases associated with B-cell lymphoproliferative disorders. 61
10424205 1999
505
Acquired skin disease of hemidesmosomes. 61
10379705 1999
506
[Manifestation of epidermolysis bullosa acquisita (EBA) in the ENT area]. 61
10412661 1999
507
High-dose intravenous immune globulin for the treatment of autoimmune blistering diseases: an evaluation of its use in 14 cases. 61
10354024 1999
508
When to request immunofluorescence: practical hints. 61
10188840 1999
509
Does class switching contribute to remission in bullous pemphigoid? 61
10228631 1999
510
IgA multiple myeloma presenting as an acquired bullous disorder. 61
10098286 1999
511
NC1 domain of type VII collagen binds to the beta3 chain of laminin 5 via a unique subdomain within the fibronectin-like repeats. 61
9989793 1999
512
Epidermolysis bullosa acquisita with combined features of bullous pemphigoid and cicatricial pemphigoid. 61
10393462 1999
513
New insights into the immunoultrastructural organization of cutaneous basement membrane zone molecules. 61
9858132 1998
514
Severe, refractory epidermolysis bullosa acquisita complicated by an oesophageal stricture responding to intravenous immune globulin. 61
9990396 1998
515
A case of nonscarring inflammatory epidermolysis bullosa acquisita: characterization of IgG autoantibodies by immunofluorescence, immunoblotting and immunogold electron microscopy. 61
9830267 1998
516
Anti-epiligrin cicatricial pemphigoid: a case associated with gastric carcinoma and features resembling epidermolysis bullosa acquisita. 61
10025973 1998
517
Molecular cloning and characterization of a cDNA encoding canine type VII collagen non-collagenous (NC1) domain, the target antigen of autoimmune disease epidermolysis bullosa acquisita (EBA). 61
9784596 1998
518
Epidermolysis bullosa acquisita in a 6-year-old Japanese boy. 61
9732011 1998
519
Complement-fixing abilities and IgG subclasses of autoantibodies in epidermolysis bullosa acquisita. 61
9752800 1998
520
Lichen planus pemphigoides is a heterogeneous disease: a report of five cases studied by immunoelectron microscopy. 61
9747357 1998
521
'Suction split' as a routine method to differentiate epidermolysis bullosa acquisita from bullous pemphigoid. 61
9643329 1998
522
[Epidermolysis bullosa acquisita and metastatic cancer of the uterine cervix]. 61
9747279 1998
523
Bullous pemphigoid and epidermolysis bullosa acquisita: presentation, prognosis, and immunopathology in 11 children. 61
9655312 1998
524
Application of confocal laser scanning microscopy to differential diagnosis of bullous pemphigoid and epidermolysis bullosa acquisita. 61
9640362 1998
525
[Epidermolysis bullosa acquisita and hepatitis C]. 61
9747265 1998
526
The use of skin substrates deficient in basement membrane molecules for the diagnosis of subepidermal autoimmune bullous disease. 61
9649654 1998
527
Epidermolysis bullosa acquisita in childhood. 61
9529688 1998
528
Dermatological uses of high-dose intravenous immunoglobulin. 61
9449914 1998
529
Prevalences of subacute cutaneous lupus erythematosus and Epidermolysis bullosa acquisita among Korean/Oriental populations. 61
9732174 1998
530
Epidermolysis bullosa acquisita localized to the face. 61
9519604 1998
531
Molecular biological aspects of acquired bullous diseases. 61
9603234 1998
532
A case of an inflammatory variant of epidermolysis bullosa acquisita: chronic bullous dermatosis associated with nonscarring mucosal blisters and circulating IgG anti-type-VII-collagen antibody. 61
9693189 1998
533
Epidermal-binding circulating antibodies in epidermolysis bullosa acquisita: what are they? 61
9536252 1998
534
A novel variant of acquired epidermolysis bullosa with autoantibodies against the central triple-helical domain of type VII collagen. 61
9426400 1997
535
Psoriasis vulgaris coexistent with epidermolysis bullosa acquisita. 61
9415242 1997
536
Mucocutaneous features of autoimmune blistering diseases. 61
9394385 1997
537
A subepidermal blistering disease with histopathological features of dermatitis herpetiformis and immunofluorescence characteristics of bullous pemphigoid: a novel subepidermal blistering disease or a variant of bullous pemphigoid? 61
9390339 1997
538
Electron microscopy and morphometry enhances differentiation of epidermolysis bullosa subtypes. With normal values for 24 parameters in skin. 61
9444386 1997
539
Linear IgA disease: a report of two dermal binding sera which recognize a pepsin-sensitive epitope (?NC-1 domain) of collagen type VII. 61
9390326 1997
540
Epidermolysis bullosa acquisita in childhood--a case mimicking chronic bullous dermatosis of childhood. 61
9536542 1997
541
Epidermolysis bullosa acquisita diagnosed by direct immunoelectron microscopy of the conjunctiva. 61
9307635 1997
542
Epidermolysis bullosa acquisita in childhood. 61
9301589 1997
543
Diagnostic value of indirect immunofluorescence on sodium chloride-split skin in differential diagnosis of subepidermal autoimmune bullous dermatoses. 61
9301587 1997
544
Epidermolysis bullosa acquisita in a 10-year-old Albanian boy. 61
9292091 1997
545
IgA-epidermolysis bullosa acquisita in a child resulting in blindness. 61
9292080 1997
546
Human skin basement membrane in health and in autoimmune diseases. 61
9232815 1997
547
Successful treatment of epidermolysis bullosa acquisita with mesalazine. 61
9274650 1997
548
Epidermolysis bullosa acquisita. 61
9301162 1997
549
Linear IgA disease with clinical and immunopathological features of epidermolysis bullosa acquisita. 61
9263315 1997
550
Epidermolysis bullosa acquisita exacerbated by systemic estrogen and progesterone treatment and pregnancy. 61
9146549 1997
551
An extract from cultured human keratinocytes that contains the major autoantigens related to autoimmune bullous skin diseases. 61
9168403 1997
552
Epidermolysis bullosa acquisita associated with epidermal-binding circulating antibodies. 61
9155969 1997
553
Evaluation of an avidin-biotin-peroxidase method with a monoclonal antibody to type IV collagen in the differential diagnosis of bullous pemphigoid and epidermolysis bullosa acquisita. 61
9164061 1997
554
Treatment of refractory epidermolysis bullosa acquisita with extracorporeal photochemotherapy. 61
9115929 1997
555
The presence of anti-basement membrane zone antibodies in the sera of patients with non-bullous lupus erythematosus. 61
9068736 1997
556
Intravenous immunoglobulin treatment in therapy-resistant epidermolysis bullosa acquisita. 61
9039213 1997
557
Nonscarring inflammatory epidermolysis bullosa acquisita with esophageal involvement and linear IgG deposits. 61
9039210 1997
558
Development of an ELISA for rapid detection of anti-type VII collagen autoantibodies in epidermolysis bullosa acquisita. 61
8980290 1997
559
Cyclosporine in the treatment of dermatologic disease: an update. 61
8945493 1996
560
Penicillamine-induced bullous dermatoses. 61
8912569 1996
561
Epidermolysis bullosa acquisita and benign schwannoma. 61
8784289 1996
562
Localized epidermolysis bullosa acquisita of the esophagus in a patient with Crohn's disease. 61
8759686 1996
563
[Cellular adhesion molecules and components of the extracellular matrix as target structures of autoimmunity]. 61
8927591 1996
564
Differences in the anti-basement membrane zone antibodies in ocular and pseudo-ocular cicatricial pemphigoid. 61
8670753 1996
565
Colchicine for epidermolysis bullosa acquisita. 61
8632074 1996
566
Two cases of atypical bullous disease showing linear IgG and IgA deposition in the basement membrane zone. 61
8935340 1996
567
[Linear IgA bullous dermatosis in children with autoantibodies against 180 kDa pemphigoid antigen]. 61
8762956 1996
568
[Therapeutic experiences with extracorporeal photopheresis. Technical procedure, follow-up and clinical outcome in 31 skin diseases]. 61
8868455 1996
569
Bullous pemphigoid and epidermolysis bullosa acquisita. Differentiation by fluorescence overlay antigen mapping. 61
8629822 1996
570
A case of linear IgA bullous dermatosis with IgA anti-type VII collagen autoantibodies. 61
8746352 1996
571
Epidermolysis bullosa acquisita: report of a case with comparison of immunogold electron microscopy using pre- and postembedding labelling. 61
8745903 1996
572
Distribution of HLA class II alleles in Korean patients with epidermolysis bullosa acquisita. 61
8993959 1996
573
[Histology of supepidermal bullous dermatoses]. 61
9065014 1996
574
[Cell adhesion molecules and extracellular matrix components as target structures of autoimmunity]. 61
9065056 1996
575
Recent progress in studies on autoantigens for various autoimmune blistering skin diseases. 61
8587223 1995
576
Bullous systemic lupus erythematosus--a case report and review. 61
8839001 1995
577
Comparative study of autoantigens for various bullous skin diseases by immunoblotting using different dermo-epidermal separation techniques. 61
8857335 1995
578
Anti-basement membrane autoantibodies in patients with anti-epiligrin cicatricial pemphigoid bind the alpha subunit of laminin 5. 61
7561156 1995
579
Childhood bullous pemphigoid--report of a case with dermal fluorescence on salt-split skin. 61
7577594 1995
580
Laryngeal manifestations of epidermolysis bullosa acquisita. 61
7646856 1995
581
Remission of severe epidermolysis bullosa acquisita induced by extracorporeal photochemotherapy. 61
8547007 1995
582
The use of Michel's transport medium for immunofluorescence and immunoelectron microscopy in autoimmune bullous diseases. 61
7499578 1995
583
Interstitial collagenase is expressed by keratinocytes that are actively involved in reepithelialization in blistering skin disease. 61
7539470 1995
584
Passive transfer of autoantibodies from a patient with mutilating epidermolysis bullosa acquisita induces specific alterations in the skin of neonatal mice. 61
7741548 1995
585
Successful treatment of epidermolysis bullosa acquisita using intravenous immunoglobulins. 61
7772494 1995
586
Localized cicatricial pemphigoid of the Brunsting-Perry type with transition into disseminated cicatricial pemphigoid. Report of a case proved by preembedding immunogold electron microscopy. 61
7741546 1995
587
Serum eosinophil cationic protein (ECP) in bullous pemphigoid. 61
7751092 1995
588
Childhood acquired epidermolysis bullosa. 61
7792213 1995
589
Fatal vascular involvement in systemic lupus erythematosus following epidermolysis bullosa acquisita. 61
7604645 1995
590
Major antigenic epitopes of bullous pemphigoid 230 kDa antigen map within the C-terminal end of the protein. Evidence using a 55 kDa recombinant protein. 61
7534103 1995
591
Immunodominant autoepitopes of type VII collagen are short, paired peptide sequences within the fibronectin type III homology region of the noncollagenous (NC1) domain. 61
7530271 1995
592
Corneal perforation as a complication of epidermolysis bullosa acquisita. 61
8543086 1995
593
[Pemphigoid mimicking epidermolysis bullosa acquisita]. 61
7668776 1995
594
Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group. 61
7826096 1995
595
Crescentic glomerulonephritis in a patient with epidermolysis bullosa acquisita. 61
7617096 1995
596
Childhood epidermolysis bullosa acquisita. 61
7857848 1994
597
Epidermolysis bullosa acquisita. 61
7999613 1994
598
Epidermolysis bullosa acquisita: efficacy of high-dose intravenous immunoglobulins. 61
7929940 1994
599
Linear IgA bullous dermatosis with autoantibodies to a 290 kd antigen of anchoring fibrils. 61
7962741 1994
600
Linear IgA bullous dermatosis of childhood with autoantibodies to a 230 kDa epidermal antigen. 61
8041654 1994
601
Acquired bullous diseases of childhood: re-evaluation of diagnosis by indirect immunofluorescence examination on 1 M NaCl split skin and immunoblotting. 61
8204469 1994
602
Difference in binding sites of autoantibodies against 230- and 170-kD bullous pemphigoid antigens on salt-split skin. 61
8176249 1994
603
Epitope mapping for epidermolysis bullosa acquisita autoantibody by molecularly cloned cDNA for type VII collagen. 61
7513737 1994
604
Epidermolysis bullosa acquisita with features of bullous lupus erythematosus. 61
8169020 1994
605
[Inflammatory type of epidermolysis bullosa acquisita]. 61
8175345 1994
606
A novel immune-mediated subepidermal bullous dermatosis characterized by IgG autoantibodies to a lower lamina lucida component. 61
8129413 1994
607
Identification of a novel basement membrane antigen (p84) defined by sera with antibodies to both the epidermal and dermal side of split skin. 61
8106753 1994
608
The immunofluorescence evaluation of some subepidermal bullous diseases by use of NaCl-split skin. 61
7784801 1994
609
Optimal conditions of 1 M NaCl splitting technique to demonstrate basement membrane zone antigens in bullous pemphigoid, epidermolysis bullosa acquisita and linear IgA bullous dermatoses. 61
8049556 1994
610
Production of monoclonal antibodies against the N-terminal noncollagenous domain of type VII collagen encoded by epidermolysis bullosa acquisita antigen cDNA. 61
7519486 1994
611
A retrospective analysis of tissue-fixed immunoreactants from skin biopsies maintained in Michel's medium. 61
8049555 1994
612
Epidermolysis bullosa acquisita--successful treatment with colchicine. 61
8141610 1994
613
Epidermolysis bullosa acquisita--a case with upper airways obstruction requiring tracheostomy and responding to cyclosporin. 61
8252795 1993
614
Epitope mapping of type VII collagen. Identification of discrete peptide sequences recognized by sera from patients with acquired epidermolysis bullosa. 61
7691888 1993
615
Skin explant culture: a reliable method for detecting pemphigoid antibodies in pemphigoid sera that are negative by standard immunofluorescence and immunoblotting. 61
8409535 1993
616
Drug-induced cicatricial pemphigoid and acquired epidermolysis bullosa. 61
8124642 1993
617
Epidermolysis bullosa acquisita: efficacy of high-dose intravenous immunoglobulins. 61
8340508 1993
618
Non-infectious diseases of the oral soft tissue: a new approach. 61
8260011 1993
619
Epidermolysis bullosa acquisita and bullous systemic lupus erythematosus. Diseases of autoimmunity to type VII collagen. 61
8365038 1993
620
Epidermolysis bullosa acquisita occurring in association with systemic lupus erythematosus. 61
8403483 1993
621
Inflammatory bullous diseases in children. 61
8365040 1993
622
Floor-pattern salt-split skin cannot distinguish bullous pemphigoid from epidermolysis bullosa acquisita. Use of toad skin. 61
8507077 1993
623
Expression of cross-reactive idiotypes at the basement membrane zone in patients with bullous pemphigoid. 61
8496615 1993
624
Autoantibodies to type VII collagen recognize epitopes in a fibronectin-like region of the noncollagenous (NC1) domain. 61
7684054 1993
625
Labeling of fractured human skin with antibodies to BM 600/nicein, epiligrin, kalinin and other matrix components. 61
8357788 1993
626
Hermann Pinkus Memorial Lecture--1992. Autoimmunity to collagen VII: Autoantibody-mediated pathomechanisms regulate clinical-pathological phenotypes of acquired epidermolysis bullosa and bullous SLE. 61
8320353 1993
627
Bullous eruption of systemic lupus erythematosus: a clinicopathological study of four cases. 61
8471519 1993
628
Epidermolysis bullosa acquisita (EBA) with nonclassical distribution of eruptions. 61
8478495 1993
629
Vulvar involvement in autoimmune bullous diseases. 61
8445600 1993
630
Bullous SLE: a phenotypically distinctive but immunologically heterogeneous bullous disorder. 61
8423389 1993
631
Brunsting-Perry cicatricial bullous pemphigoid: a clinical variant of localized acquired epidermolysis bullosa? 61
8425977 1993
632
[Acquired localized epidermolysis bullosa. A case with scalp involvement and immunoelectron microscopic study]. 61
8279794 1993
633
Differences in direct immunofluorescence staining patterns in epidermolysis bullosa acquisita and bullous pemphigoid. 61
1430385 1992
634
Epidermolysis bullosa acquisita in a 3 1/2-year-old girl. 61
1469146 1992
635
Epidermolysis bullosa acquisita presenting with localized facial blisters. 61
1458648 1992
636
Epidermolysis bullosa acquisita with oesophageal stenosis. 61
1390148 1992
637
In situ localization of IgG in epidermolysis bullosa acquisita by immunogold technique. 61
1290534 1992
638
Subtle differences in the morphology of bullous lesions between epidermolysis bullosa acquisita and bullous pemphigoid. 61
1401503 1992
639
Epidermolysis bullosa acquisita induced by GM-CSF: a role for eosinophils in treatment-related toxicity. 61
1520621 1992
640
In situ localization of IgG in epidermolysis bullosa acquisita by immunogold technique. 61
1583172 1992
641
Serological diagnosis of bullous pemphigoid (BP): comparison of the sensitivity of indirect immunofluorescence on salt-split skin to immunoblotting. 61
1554599 1992
642
Molecular cloning and characterization of type VII collagen cDNA. 61
1567409 1992
643
Histologic and immunofluorescence study of cutaneous porphyrias. 61
1556265 1992
644
Expression of the alpha 6 beta 4 integrin in lesional skin differentiates bullous pemphigoid (BP) from epidermolysis bullosa acquisita (EBA). 61
1732384 1992
645
Epidermolysis bullosa acquisita, a rare late complication of allogeneic bone marrow transplantation? 61
1571712 1992
646
[The dermo-epidermal junction and its acquired and hereditary pathology. A few recent advances]. 61
1608653 1992
647
The role of complement-derived mediators in inflammatory skin diseases. 61
1285651 1992
648
Identification of cicatricial pemphigoid antigens. 61
1739288 1992
649
Studies on complement deposits in epidermolysis bullosa acquisita and bullous pemphigoid. 61
1371212 1992
650
Differentiation of bullous pemphigoid from epidermolysis bullosa acquisita on frozen skin biopsies. 61
1737687 1992
651
Circulating anti-glomerular basement membrane antibodies in coeliac disease and epidermolysis bullosa acquisita. 61
1818546 1991
652
Epidermolysis bullosa acquisita (EBA) and esophageal webs: a new association. 61
1928049 1991
653
Differential diagnosis of bullous pemphigoid and epidermolysis bullosa acquisita. 61
1794202 1991
654
Autoimmunity to type VII collagen. 61
1931572 1991
655
Autoantibodies to human stress proteins. A survey of various rheumatic and other inflammatory diseases. 61
1930332 1991
656
Transient intraepidermal bullous reaction after skin graft for toxic epidermal necrolysis. Ultrastructural and immunohistochemical features similar to those of inherited epidermolysis bullosa simplex. 61
1892406 1991
657
Human type VII collagen: cDNA cloning and chromosomal mapping of the gene. 61
1871109 1991
658
The subclass distribution of IgG autoantibodies in cicatricial pemphigoid and epidermolysis bullosa acquisita. 61
2071938 1991
659
Cicatricial pemphigoid antigen differs from bullous pemphigoid antigen by its exclusive extracellular localization: a study by indirect immunoelectronmicroscopy. 61
2056190 1991
660
Bazex syndrome (acrokeratosis paraneoplastica). An analytic review. 61
2067411 1991
661
Cicatricial pemphigoid. 61
1869688 1991
662
Clearing of epidermolysis bullosa acquisita with cyclosporine. 61
1869675 1991
663
Childhood epidermolysis bullosa acquisita. Report of three cases and review of literature. 61
1869641 1991
664
Epidermolysis bullosa acquisita in identical twins. 61
1918598 1991
665
Epidermolysis bullosa acquisita and associated symptomatic esophageal webs. 61
1998368 1991
666
Acquired epidermolysis bullosa with the clinical feature of Brunsting-Perry cicatricial bullous pemphigoid. 61
1998371 1991
667
Childhood bullous pemphigoid. Clinical and immunologic features, treatment, and prognosis. 61
1998369 1991
668
Identification of the target antigen in chronic bullous disease of childhood and linear IgA disease of adults. 61
2003998 1991
669
Clear-cell carcinoma of the lung in a patient treated with cyclosporine for epidermolysis bullosa acquisita. 61
2007684 1991
670
Epidermolysis bullosa acquisita: a disease of autoimmunity to type VII collagen. 61
2031664 1991
671
[Epidermolysis bullosa acquisita]. 61
1897836 1991
672
Location of basement membrane type IV collagen beneath subepidermal bullous diseases. 61
2074279 1990
673
Absence of platelet aggregation activity in blister fluids from epidermolysis bullosa dystrophica and epidermolysis bullosa acquisita. 61
2288902 1990
674
Repeat direct immunofluorescence to discriminate pemphigoid from epidermolysis bullosa acquisita. 61
2221945 1990
675
Acquired epidermolysis bullosa. A bullous disease associated with autoimmunity to type VII (anchoring fibril) collagen. 61
2249362 1990
676
Heavy and light chain isotypes of immunoglobulin in epidermolysis bullosa acquisita. 61
2117036 1990
677
Epidermolysis bullosa acquisita antigen and the carboxy terminus of type VII collagen have a common immunolocalization to anchoring fibrils and lamina densa of basement membrane. 61
2354110 1990
678
High expression of multinucleated giant cells in cultures of peripheral blood cells from HIV infected patients. 61
2227616 1990
679
Studies of cicatricial pemphigoid autoantibodies using direct immunoelectron microscopy and immunoblot analysis. 61
2182720 1990
680
Epidermolysis bullosa acquisita preceding the development of systemic lupus erythematosus. 61
2319019 1990
681
Direct immunofluorescence studies of sodium chloride-separated skin in the differential diagnosis of bullous pemphigoid and epidermolysis bullosa acquisita. 61
2180996 1990
682
Oral cyclosporine in the treatment of inflammatory and noninflammatory dermatoses. A clinical and immunopathologic analysis. 61
2178558 1990
683
Clearing of epidermolysis bullosa acquisita with cyclosporine. 61
2312839 1990
684
Epidermolysis bullosa acquisita. Incidence in patients with basement membrane zone antibodies. 61
2134155 1990
685
Immunofluorescence on salt-split skin for the diagnosis of epidermolysis bullosa acquisita. 61
2405782 1990
686
[Clinical, histopathologic, immunofluorescent and ultrastructural estimation of 2 cases of epidermolysis bullosa acquisita]. 61
1670034 1990
687
[Acquired epidermolysis bullosa. Current state of knowledge]. 61
2260802 1990
688
[Acquired epidermolysis bullosa in children. Report of a case]. 61
2099689 1990
689
Intractable epidermolysis bullosa acquisita: efficacy of cyclosporin A. 61
2394303 1990
690
[Acquired bullous epidermolysis and multiple myeloma]. 61
2263100 1990
691
Epidermolysis Bullosa Acquisita. 61
28128127 1989
692
The localization of the bullous pemphigoid and cicatricial pemphigoid antigens: direct and indirect immunofluorescence of suction blisters. 61
2679855 1989
693
[Lichen planus pemphigoides--report of a case and binding sites of circulating anti-basement membrane zone antibodies]. 61
2691740 1989
694
Epidermolysis bullosa acquisita in childhood. Differentiation from hereditary epidermolysis bullosa. 61
2662910 1989
695
Epidermolysis Bullosa Acquisita (Report of three Cases). 61
28128181 1989
696
Clinical correlations of linear IgA deposition at the cutaneous basement membrane zone. 61
2654216 1989
697
Defective expression of basement membrane-associated C3d,g in papulonodular basal cell carcinomas. 61
2654297 1989
698
Trauma-induced bullous pemphigoid. 61
2686871 1989
699
[Immunomapping in localized bullous pemphigoid]. 61
2659551 1989
700
Identification of the epidermolysis bullosa acquisita antigen by LH 7.2 monoclonal antibody: use in diagnosis. 61
2730844 1989
701
Sunbed-induced pseudoporphyria. 61
2730845 1989
702
Ocular involvement in epidermolysis bullosa acquisita. 61
2647069 1989
703
[Value of colchicine in treating acquired epidermolysis bullosa]. 61
2675732 1989
704
Diagnosis of adult linear IgA dermatosis by immunoelectronmicroscopy in 16 patients with linear IgA deposits. 61
2642511 1989
705
Bulla spreading sign for differentiating epidermolysis bullosa acquisita from bullous pemphigoid. 61
28112122 1989
706
The presence of intra-lamina lucida blister formation in epidermolysis bullosa acquisita: possible role of leukocytes. 61
2642510 1989
707
Synthesis of epidermolysis bullosa acquisita antigen by simian virus 40-transformed human keratinocytes. 61
2543335 1989
708
Epidermal basement membrane alterations in epidermolysis bullosa acquisita. 61
3074092 1988
709
Clearing of epidermolysis bullosa acquisita with cyclosporine. 61
3057000 1988
710
[The basement membrane and its significance in congenital and acquired diseases of the skin]. 61
3070989 1988
711
Epidermolysis bullosa acquisita. 61
3153447 1988
712
Increased frequency of HLA-DR2 in patients with autoantibodies to epidermolysis bullosa acquisita antigen: evidence that the expression of autoimmunity to type VII collagen is HLA class II allele associated. 61
3137269 1988
713
C3d,g is present in normal human epidermal basement membrane. 61
3135326 1988
714
Epidermolysis bullosa acquisita. 61
3414910 1988
715
Pemphigoid and ulcerative colitis. 61
3049690 1988
716
Epidermolysis bullosa acquisita and total ulcerative colitis. 61
3418663 1988
717
Epidermolysis bullosa acquisita associated with vesicular cystitis. 61
3408651 1988
718
Systemic lupus erythematosus presenting as a bullous eruption in a child. 61
3291780 1988
719
Epidermolysis bullosa acquisita and Crohn's disease. A case report with immunological and electron microscopic studies. 61
2897835 1988
720
[Acquired epidermolysis bullosa. A clinico-pathologic study]. 61
3042704 1988
721
Review and update of epidermolysis bullosa acquisita. 61
3153432 1988
722
[Epidermolysis bullosa acquisita with negative direct immunofluorescence in a patient with myeloma]. 61
3067040 1988
723
Administration of IgG fraction of epidermolysis bullosa acquisita (EBA) serum into mice. 61
3049728 1988
724
Epidermolysis bullosa acquisita antigen is the globular carboxyl terminus of type VII procollagen. 61
3278005 1988
725
Epidermolysis bullosa acquisita antigen: relationship between the collagenase-sensitive and -insensitive domains. 61
2828479 1988
726
Distribution of the antigen in adult linear IgA disease and chronic bullous dermatosis of childhood suggests that it is a single and unique antigen. 61
2831930 1988
727
Human nevocellular nevus cells are surrounded by basement membrane components. Immunohistologic studies of human nevus cells and melanocytes in vivo and in vitro. 61
3276959 1988
728
Persistent subepidermal blistering in split-thickness skin graft sites. Ultrastructural and antigenic features simulating dystrophic or immunofluorescence-negative acquired epidermolysis bullosa. 61
3277544 1988
729
Antigen specificities of antibasement membrane zone antibodies: immunofluorescence and Western immunoblotting studies. 61
2462854 1988
730
[Acquired epidermolysis bullosa. Apropos of a clinical case]. 61
3417333 1988
731
Autoantibodies to extracellular collagen matrix components in epidermolysis bullosa and other bullous diseases. 61
3056284 1988
732
Cyclosporine A in epidermolysis bullosa acquisita. 61
3429719 1987
733
Functional heterogeneity of immune complexes in epidermolysis bullosa acquisita. 61
3668292 1987
734
Epidermolysis bullosa acquisita associated with lymphoma. 61
3680671 1987
735
Naproxen-induced pseudoporphyria presenting a diagnostic dilemma. 61
3677793 1987
736
Localization of bullous pemphigoid antibody--an indirect immunofluorescence study of 228 cases using a split-skin technique. 61
3314971 1987
737
Sequence of reconstitution of seven basement-membrane components following split-thickness wound induction in primate skin. 61
3632002 1987
738
Epidermolysis bullosa acquisita. Direct immunofluorescence and ultrastructural studies. 61
3307479 1987
739
Childhood epidermolysis bullosa acquisita. Detection in a 5-year-old girl. 61
3555356 1987
740
Specific affinity between fibronectin and the epidermolysis bullosa acquisita antigen. 61
3584471 1987
741
Bullous pemphigoid. 61
3294944 1987
742
Multiple clear cell acanthomas. Case report and delineation of basement membrane zone antigens. 61
3294947 1987
743
Gold therapy and its indications in dermatology. A review. 61
3553248 1987
744
Treatment of epidermolysis bullosa acquisita with cyclosporine. 61
3571559 1987
745
Severe ocular involvement in a patient with epidermolysis bullosa acquisita. 61
3819091 1987
746
Neonatal foreskin substrate has limitations for the immunofluorescent screening of monoclonal antibodies. 61
3543143 1987
747
Pathology of pemphigoid. 61
3552195 1987
748
Importance of the dermal-epidermal junction and recent advances. 61
3542613 1987
749
Disseminated cicatricial pemphigoid in a child and in an adult. Ultrastructural diagnostic criteria and differential diagnosis with special reference to acquired epidermolysis bullosa. 61
3314733 1987
750
Epidermolysis bullosa acquisita with negative direct immunofluorescence. 61
3527078 1986
751
Epidermolysis bullosa acquisita in an 8-year-old girl. 61
3774650 1986
752
Epidermolysis bullosa acquisita with negative direct immunofluorescence. 61
3527071 1986
753
Bullous systemic lupus erythematosus: an unusual clinical course and detectable circulating autoantibodies to the epidermolysis bullosa acquisita antigen. 61
3525621 1986
754
Epidermolysis bullosa acquisita antigen, a major cutaneous basement membrane component, is synthesized by human dermal fibroblasts and other cutaneous tissues. 61
3525689 1986
755
Epidermolysis bullosa acquisita--mapping of antigenic determinants by an immunofluorescent technique. 61
2433082 1986
756
Epidermolysis bullosa acquisita antigen, a new major component of cutaneous basement membrane, is a glycoprotein with collagenous domains. 61
3519786 1986
757
Anatomical distribution and immunological characteristics of epidermolysis bullosa acquisita antigen and bullous pemphigoid antigen. 61
3521710 1986
758
Epidermolysis bullosa acquisita: clinical response to plasma exchange therapy and circulating anti-basement membrane zone antibody titer. 61
3086389 1986
759
Subepidermal vesicular dermatosis and sensory peripheral neuropathy caused by pyridoxine abuse. 61
3011864 1986
760
Acquired epidermolysis bullosa without basement membrane zone immunoreactants. 61
3958279 1986
761
Organ-specific, phylogenetic, and ontogenetic distribution of the epidermolysis bullosa acquisita antigen. 61
3745957 1986
762
Epidermolysis bullosa acquisita in a patient with multiple endocrinopathies syndrome. 61
3947126 1986
763
Epidermolysis bullosa acquisita. The search for identity. 61
3947122 1986
764
[Vesiculo-bullous lupus erythematosus. Immuno-electronic study]. 61
3541759 1986
765
The alteration in gingival basement membrane antigens in chronic periodontitis. 61
3511218 1986
766
Epidermolysis bullosa acquisita antigen is synthesized by both human keratinocytes and human dermal fibroblasts. 61
2415640 1985
767
Cicatricial pemphigoid, bullous pemphigoid, and epidermolysis bullosa acquisita antigens: differences in organ and species specificities and localization in chemically-separated human skin of three basement membrane antigens. 61
3902344 1985
768
Epidermolysis bullosa acquisita with negative direct immunofluorescence. 61
3899018 1985
769
Epidermolysis bullosa acquisita antigen is synthesized by human keratinocytes cultured in serum-free medium. 61
2411267 1985
770
The regeneration of gingival basement membrane antigens during secondary wound healing. 61
3894615 1985
771
Epidermolysis bullosa: variability of expression of cicatricial pemphigoid, bullous pemphigoid, and epidermolysis bullosa acquisita antigens in clinically uninvolved skin. 61
3891876 1985
772
Epidermolysis bullosa acquisita of the immunopathological type (dermolytic pemphigoid). 61
4008982 1985
773
Evidence that anti-basement membrane zone antibodies in bullous eruption of systemic lupus erythematosus recognize epidermolysis bullosa acquisita autoantigen. 61
3889170 1985
774
Epidermolysis bullosa acquisita associated with chronic lymphatic leukaemia. 61
3978864 1985
775
A mouse monoclonal antibody against a newly discovered basement membrane component, the epidermolysis bullosa acquisita antigen. 61
3882847 1985
776
[Acquired epidermolysis bullosa (acquired dermolytic bullous dermatoses) (study of 2 patients)]. 61
3912631 1985
777
[Acquired epidermolysis bullosa combined with thrombocytopenia]. 61
3976296 1985
778
The epidermal basement membrane zone--structure, ontogeny, and role in disease. 61
6512049 1984
779
The basement membrane autoantigen in epidermolysis bullosa acquisita. 61
6526557 1984
780
Epidermolysis bullosa acquisita--a pemphigoid-like disease. 61
6392361 1984
781
Differences in complement-dependent chemotactic activity generated by bullous pemphigoid and epidermolysis bullosa acquisita immune complexes: demonstration by leukocytic attachment and organ culture methods. 61
6376640 1984
782
Basement membrane reactivity of antisera to type IV collagen and sera from patients with bullous pemphigoid and epidermolysis bullosa acquisita. 61
6400590 1984
783
Identification of the skin basement-membrane autoantigen in epidermolysis bullosa acquisita. 61
6369131 1984
784
Differentiating anti-lamina lucida and anti-sublamina densa anti-BMZ antibodies by indirect immunofluorescence on 1.0 M sodium chloride-separated skin. 61
6363567 1984
785
Epidermolysis bullosa acquisita: an autoimmune disease with distinctive immunoultrastructural features. 61
6357643 1983
786
Junctional blisters in acquired bullous disorders of the dermal-epidermal junction zone: role of the lamina lucida as the mechanical locus minoris resistentiae. 61
6357262 1983
787
Epidermolysis bullosa acquisita and inflammatory bowel disease. 61
6887488 1983
788
[Epidermolysis bullosa acquisita--manifestations in otorhinolaryngology]. 61
6358736 1983
789
Epidermolysis bullosa acquisita diagnosed by immunoelectron microscopy. 61
6366010 1983
790
Epidermolysis bullosa acquisita with pulmonary tuberculosis: a case report. 61
6883798 1983
791
Pregnancy as a trigger of epidermolysis bullosa acquisita. 61
6195871 1983
792
Double immunofluorescence microscopy: a method for localizing immune deposits in skin diseases associated with linear basement membrane zone immunofluorescence. 61
6752293 1982
793
[Plasmocytoma-associated bullous hemorrhagic amyloidosis of the skin]. 61
6759462 1982
794
Epidermolysis bullosa acquisita presenting as an inflammatory bullous disease. 61
6752224 1982
795
[Epidermolysis bullosa acquisita: diagnosis by optic immunofluorescent demonstration of junctional antigens and vitamin E treatment]. 61
6179897 1982
796
Immunoelectron microscopic findings in cicatricial pemphigoid: their significance in relation to epidermolysis bullosa acquisita. 61
7041948 1982
797
Epidermolysis bullosa acquisita and inflammatory bowel disease. 61
7037881 1982
798
[Bullous pemphigoid induced by photochemotherapy of psoriasis. Apropos of 2 cases, with a review of the literature]. 61
6753695 1982
799
[Acquired epidermolysis bullosa with Crohn's disease. Report of two cases and review of literature (author's transl)]. 61
7041773 1982
800
[Epidermolysis bullosa acquisita (EBA). Morphological, immunocytochemical, optical and ultrastructural study about one case (author's transl)]. 61
7037018 1982
801
Bullous dermatosis associated with dysglobulinemia (two cases). Relationships with epidermolysis bullosa acquisita. 61
6762227 1982
802
The mechanobullous diseases. Hereditary epidermolysis bullosa and epidermolysis bullosa acquisita. 61
7033310 1981
803
Ultrastructural and immuno-electron microscopic study in a case of epidermolysis bullosa acquisita. 61
7336921 1981
804
Epidermolysis bullosa acquisita: a heterogeneous disease. 61
7024335 1981
805
Epidermolysis bullosa acquisita. 61
7259215 1981
806
Systemic lupus erythematosus occurring in a patient with epidermolysis bullosa acquisita. 61
7259221 1981
807
Epidermolysis bullosa acquisita: ultrastructural and immunological studies. 61
7009764 1981
808
Bullous amyloidosis vs epidermolysis bullosa acquisita. 61
7001078 1981
809
The relationship of epidermolysis bullosa acquisita to cicatricial pemphigoid. 61
7015907 1981
810
[Epidermolysis bullosa acquisita? Cicatricial pemphigoid?]. 61
7013309 1980
811
Epidermolysis bullosa acquisita: a clinical disorder of varied etiologies. Two cases and a review of immunologic and other reported findings. 61
7005274 1980
812
Acidic glycosaminoglycans in cultured skin fibroblasts of a patient with epidermolysis bullosa acquisita. 61
7404577 1980
813
Epidermolysis bullosa acquisita. Immunofluorescence, electron microscopic and immunoelectron microscopic studies in four patients. 61
6992836 1980
814
Epidermolysis bullosa acquisita. Association with amyloidosis and multiple myeloma. 61
7359721 1980
815
Hodgkin's disease with specific bullous lesions. 61
7008639 1980
816
The spectrum of epidermolysis bullosa acquisita. 61
389167 1979
817
Epidermolysis bullosa acquisita--a sign of cicatricial pemphigoid? 61
389273 1979
818
Lesions induced by trauma in pemphigoid. 61
389272 1979
819
Unusual subepidermal bullous diseases with immunologic features of bullous pemphigoid. 61
371547 1979
820
Ultrastructural study of mechanobullous desquamative gingivitis: a case report. 61
94213 1979
821
Epidermolysis bullosa acquisita versus pemphigoid. 61
84505 1979
822
Acquired epidermolysis bullosa treated with a gold compound. 61
92161 1979
823
Immunopathology of epidermolysis bullosa acquisita. Association with mixed cryoglobulinemia. 61
354536 1978
824
Epidermolysis bullosa acquisita and Crohn's disease. 61
698090 1978
825
[Epidermolysis bullosa acquisita in multiple myeloma associated with skin amyloidosis (author's transl)]. 61
712178 1978
826
Oral lesions of epidermolysis bullosa acquisita. 61
353626 1978
827
Epidermolysis bullosa acquisita and Crohn's disease. 61
78639 1978
828
[Adquired epidermolysis bullosa. Immunopathological and ultrastructural studies]. 61
384109 1978
829
Epidermolysis bullosa acquisita. 61
884050 1977
830
Vitamin E treatment of epidermolysis bullosa acquisita. 61
1022216 1976
831
Acquired epidermolysis bullosa due to high-dose frusemide. 61
1276741 1976
832
Epidermolysis bullosa acquisita. Diagnosis by electron microscopy. 61
1000817 1976
833
Letter: Epidermolysis bullosa acquisita with electron microscopical studies. 61
1200671 1975
834
[Pathomorphogenesis of blistering in epidermolysis bullosa acquisita and epidermolysis bullosa dystrophica (author's transl)]. 61
1239240 1975
835
[Acquired epidermolysis bullosa in Crohn's disease]. 61
1100568 1975
836
Epidermolysis bullosa acquisita with electron microscopical studies. 61
1115511 1975
837
The immunopathology of epidermolysis bullosa acquisita. 61
4574408 1973
838
Epidermolysis bullosa acquisita and Crohn's disease. 61
4697982 1973
839
Therapeutic value of large doses of vitamin E in epidermolysis bullosa acquisita. 61
4664567 1972
840
Case report: epidermolysis bullosa acquisita. 61
5082493 1972
841
Epidermolysis bullosa acquisita. Report of three cases and review of all published cases. 61
4321800 1971
842
[Epidermolysis bullosa "acquisita"]. 61
5509185 1970
843
Histochemical study on the pathogenesis of epidermolysis bullosa acquisita. 61
4186929 1969
844
Amyloidosis masquerading as epidermolysis bullosa acquisita. 61
5783088 1969
845
Epidermolysis bullosa acquisita with oesophageal casts. 61
6066576 1967
846
EPIDERMOLYSIS BULLOSA ACQUISITA: A DISEASE OF DERMAL CONNECTIVE TISSUE. 61
14246157 1965
847
EPIDERMOLYSIS BULLOSA ACQUISITA, DERMAL ELASTOSIS, AMYLOIDOSIS. 61
14162313 1964
848
Acquired epidermolysis bullosa. 61
13971362 1962
849
Epidermolysis bullosa acquisita (tardive) and porphyria cutanea tarda: an analytic comparison of these two conditions. 61
13820497 1959
850
[A case of acquired epidermolysis bullosa]. 61
13121270 1953
851
Epidermolysis bullosa acquisita. 61
14867924 1951
852
Epidermolysis bullosa acquisita. 61
18903027 1948
853
Epidermolysis bullosa (acquisita). 61
21001303 1946
854
Epidermolysis bullosa acquisita complicated by an annular vegetative iododerma. 61
21013483 1946
855
Acquired Epidermolysis Bullosa (?). 61
19987174 1929
856
Acquired Epidermolysis Bullosa. 61
19986844 1929